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Antimicrobial Resistance for Enteric Pathogens Isolated from 
Acute Gastroenteritis Patients in Gaza strip, Palestine. 
Abstract 
The antibiotic resistance of enteropathogenic bacteria has profound clinical 
implications. Hence, this research was in part an attempt for isolation of 
enteropathogenic bacteria and determines their antimicrobial susceptibility patterns. 
Samples were collected from acute gastroenteritis patients in Gaza strip, Palestine. 
This method of investigation is a matched case-control study. 
 
A total of 132 stool samples were collected from Palestinian patients with acute 
diarrhea (gastroenteritis). Among 132 diarrheal patients, 12 (9.1%) of 
enteropathogenic bacteria were isolated. Salmonella, Campylobacter coli/jejuni, and 
Aeromonas hydrophilia were isolated in equal numbers from samples 3/12 (25% 
each), Shigella 2/12 (16.7%), Yersinia enterocolytica 1/12 (8.3%). The two Shigella 
spp. are Shigella boydii. The antimicrobial profile of twelve isolated 
enteropathogenic bacteria showed high resistance rates for Campylobacter coli/jejuni 
(52.4%), followed by Aeromonas hydrophilia (49.2%), Yersinia enterocolytica  
(42.9%), Shigella (26.2%) and Salmonella spp. (22.2%). Children younger than 5 
years old are more susceptible to infectious diarrhea; in addition, diarrhea is more 
frequent in crowded houses with low room's number, and among peoples living in 
houses rearing poultry, and pigeons. 
 
Findings from this study demonstrated that Campylobacter coli/jejuni, Aeromonas 
hydrophilia, and Yersinia enterocolytica, which are not screened during routine 
examinations of stool samples in Palestinian health laboratories in Gaza strip, were 
significant enteropathogens in the studied patients. Therefore, we recommend 
improving of laboratories in Gaza strip to increase their ability to isolate all types of 
enteropathogenic bacteria especially those, which have not isolated routinely in these 
laboratories, which require special techniques. 
 
Keywords: Gastroenteritis, Diarrhea, Enteropathogenic bacteria, Antibiotic 
resistance, Gaza strip. 
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مقاومة البكتیریا المعویة المعزولة من مرضى االلتھابات المعویة الحادة للمضادات الحیویة 




ھذا البحث عزل البكتیریا  أھداف من لكلذ، مقاومة البكتیریا المعویة للمضادات الحیویة لھا نتائج طبیة سیئة
  .لحیویةالمعویة الممرضة وفحص مقاومتھا للمضادات ا
  
ھذا البحث تم إجراءه باستخدام . فلسطین، تم جمع العینات من مرضى االلتھابات المعویة الحادة في قطاع غزه 
  .مرضى وعینات ضابطھ
  
سھال إ مریض 132 بین من . عینھ من مرضى فلسطینیین یعانون من التھابات معویة وإسھال حاد 132تم جمع 
ایروموناس ھیدروفیال ، الكمبیلوباكتر، السلمونیال :ویة وھى كالتاليمن البكتیریا المع%) 9.1(12تم عزل 
یرسینیا انتیروكولیتكا ، %)16.7(2/12الشیجال  ثم تال ذلك، %)25(3/12عزلت بعدد متساوي 
  .الشیجال االثنتین ھما شیجال بودیاى  %).8.3(1/12
                             
 : كالتالي مقاومتھا للمضادات الحیویة یا المعزولة نسبھ عالیھ منالمضادات الحیویة للبكتیر صفح اظھر
یرسینیا انتیروكولیتكا  ،%)49.2(یتبعھا ایروموناس ھیدروفیال ، %)52.4(جیجینى /كوالىالكمبیلوباكتر 
  %). 22.2(السلمونیال ، %)26.2(الشیجال   ،%)42.9(
  
 أكثر اإلسھالباالضافھ إلى أن ، باإلسھالصابھ عرضھ لال أكثرعن خمس سنوات  أعمارھمالذین تقل  األطفال
في  حمام أو واجند یربون وبین الناس الذین، تحتوى على عدد غرف اقل التي المزدحمةالبیوت  فيانتشارا 
     .منازلھم
                  
یرسینیا  ،دروفیالایروموناس ھی، الكمبیلوباكتر نتائج ھذه الدراسة تظھر انھ تم عزل بعض البكتیریا المعویة مثل
علما أن ھذه األنواع ال تعزل من مزارع البراز في مختبرات قطاع غزه وھى من البكتیریا ، انتیروكولیتكا
لذلك نحن نوصى بتطویر المختبرات في قطاع غزه حتى تستطیع أن تعزل جمیع أنواع   .المھمة مرضیا
حیث تحتاج إلى ، رات أن تعزلھا بطریقھ روتینیھالبكتیریا المعویة وخاصة البكتیریا التي ال تستطیع المختب
  . تقنیات خاصة
  










Antibiotic resistance was reported very early in the development of these wonder 
drugs. Sir Alexander Fleming’s original report in 1929 noted that some bacteria, 
including the microbe now called Escherichia coli, were resistant to the effect of 
penicillin. In 1940, Edward Abraham and Ernst Chain reported the presence of an 
enzyme in E. coli that destroyed penicillin, this was several years before the drug 
became widely used to treat patients. In the subsequent decades, bacterial antibiotic 
resistance has become a widespread and well-known phenomenon [1]. 
 
Inappropriate prescription of antibiotics prompted resistance and increased infectious 
disease mortality not only in developing countries but also in developed countries. 
Aging populations, changes in behavior and a decline in the development of new 
antibiotics exacerbated a deteriorating situation [2]. 
 
The antibiotic resistance of enteric bacteria has profound clinical implications 
because it threats the life and causes many of serious diseases such as acute 
gastroenteritis [3]. 
 
Acute gastroenteritis is a severe infection of the gastrointestinal tract (GI). 
Sometimes people refer to it as “stomach flu” which is characterized by diarrhea, 
stomach pain, nausea, vomiting, fever or feeling unwell. Symptoms may start quite 
slowly or come on suddenly. Gastroenteritis usually passes in less than 24 hours but 
can continue for several days [4]. 
 
Diarrhea is defined as having loose or watery stools at least three times per day, or 
more frequently than normal for an individual. Though most episodes of childhood 
diarrhea are mild, acute cases can lead to significant fluid loss and dehydration, 
which may result in death [5]. 
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Acute gastroenteritis or infectious diarrhea is one of the leading causes of illnesses 
and death in infants and children throughout the world, especially in developing 
countries. This is so in Asia, Africa and Latin America, where an estimated 2.5 
million deaths occur each year in children less than 5 years of age [6,7]. Diarrhea and 
gastroenteritis is also one of the leading causes of deaths among the infants in 
Palestine, which constituted about 0.6% in 2003 [8].   
 
Worldwide, the most common pathogens that cause acute gastroenteritis are: 
Salmonella spp., Shigella spp., Campylobacter spp., E. coli O157:H7, Listeria 
monocytogenes, Vibrio cholerae, Yersinia enterocolitica, Rotavirus, 
Cryptosporidium spp., Entamoeba histolytica, and Giardia lamblia. These pathogens 
can cause potentially serious diseases, which may be fatal, especially in children. The 
common route of infection by these pathogens is the ingestion of contaminated foods 
and drinks [9].  
 
Only Salmonella spp. and Shigella spp., are routinely investigated through routine 
culture in Gaza strip [10]. Other potential pathogens (such as Campylobacter spp., 
Yersinia spp., Aeromonas spp.), however, are not routinely diagnosed. This often 
causes misdiagnosis, and physician overlooks other pathogens, and thus 
epidemiological data are inaccurate. Data from the health laboratories all over 
Palestine showed that the detection rate of Shigella spp. is very low (about 3 cases in 
2009) and even lower for Salmonella spp. (2 cases in 2009) [11]. 
 
Moreover, data concerning cases of Campylobacter, Yersinia, Aeromonas and their 
relation to infection in Palestinian children are extremely scarce [10-13].  
 
This study performed microbiological investigation of some potential pathogens 
associated with diarrhea, to characterize the isolates, their antibiotic resistance and 










To determine antimicrobial resistance for enteric pathogens isolated from acute 
gastroenteritis patients in Gaza strip, Palestine. 
 
1.2.2 Specific objective: 
 
1. To detect and identify enteric bacterial pathogens (Salmonella spp., Shigella spp., 
Campylobacter spp., Yersinia enterocolitica, Aeromonas hydrophilia) in fecal 
samples from diarrheal patients.  
2.  To assess the antibiotic susceptibility of isolated bacteria. 




Poor sanitation and restriction to water access may favour the spread of 
communicable diseases, especially infectious diarrhea, which is one of the leading 
causes of morbidity in the Gaza strip. In addition, it is one of the more frequent 
reasons for primary health care centre (PHCC) attendance in addition to respiratory 
tract infections. Infectious diarrhea affects mainly the children who are at risk of 
complications, especially when they suffer from malnutrition, which is common in 
Palestinian children. 
 
Uncontrolled use of antibiotics due to the lack of antibiotic prescribing policy in 
diarrheal infections and for any kind of suspected infection has lead to the emergence 
of bacterial resistance, which has become a major concern in Gaza [14-16]. 
 
Moreover, there is no available data about the spread and antibiotic resistance of the 
enteropathogenic bacteria. Hence, this research was in part an attempt to determine 
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the occurrence of antimicrobial resistance for enteric pathogens isolated from acute 
gastroenteritis patients in Gaza strip, Palestine. 
 
The results of this investigative work would shed light on this issue and would in part 
provide data that may prove useful for health authorities in planning properly to 
reduce the incidence of infectious diarrhea and will also aid in determining the 


































2.1 Acute gastroenteritis 
 
Acute gastroenteritis is a common childhood disease and causes significant economic 
burden to developed countries. Children in developing countries are at particular risk 
of both morbidity and mortality. Worldwide, gastroenteritis affects 3 to 5 billion 
children each year, and accounts for 1.5 to 2.5 million deaths per year or 12% of all 
deaths among children less than 5 years of age [17-20]. In developed countries, such 
as the United States, acute gastroenteritis seldom causes deaths, however, it still 
accounts for 300 deaths per year. Moreover, it puts a heavy burden on the health care 
system. Acute gastroenteritis causes 1.5 million visits to primary care providers each 
year and 220,000 hospital admissions for children under the age of 5 years; that is 
10% of all the hospital admissions of children in the United States [18]. In general, 
developing countries have a higher rate of hospital admissions as compared to 
developed countries. This may be due to the facts that children in developed 
countries have a better nutritional status and better primary care. The difference can 
also be explained by the fact that, the incidence of acute gastroenteritis is 
significantly higher in developing countries than in industrialized countries [21]. 
 
2.2 Antimicrobial resistance 
 
Antimicrobial resistance is one of the world’s most serious public health problems, 
many of the microbes (bacteria, viruses, protozoa) that cause infectious disease no 
longer respond to common antimicrobial drugs. The problem is so serious that unless 
concerted action is taken worldwide, we run the risk of returning to the pre-antibiotic 
era when many more children than now died of infectious diseases. The major 
infectious diseases kill over 11 million people per year. The prevalence rate of 
antimicrobial resistance all overall the world of diarrheal shigellosis is 10-90% for 
ampicillin and 5-95% for trimethoprim/sulfamethoxazole [22].  
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For this reason the microbial antibiotics resistance is receiving increasing attention in 
light of the increasing incidence of human bacterial infections resistant to antibiotic 
treatment [23]. The resistance of enteropathogenic bacteria to commonly prescribed 
antibiotics is increasing both in developing as well as in developed countries; 
resistance has emerged even to newer, more potent antimicrobial agents [24]. 
 
2.3 Diarrheal disease is the most common cause of illness 
 
In 2004 diarrheal disease affects far more individuals than any other illness, even in 
regions that include high-income countries. About 4620.4 million people affected 
with diarrheal disease. In addition, diarrhea is the second most common cause of 
child deaths worldwide as showed in figure (1.2) [25]. 
























2.4 Common bacterial causes of diarrhea 
 
Many types of enteropathogenic bacteria cause acute gastroenteritis and these types 
are different according to regions. In the following section, we will discuss the 
isolated enteropathogenic bacteria in this study. 
 
2.4.1 Salmonella spp. history 
 
Salmonella first identified in 1885. It was named for one of the two men who 
discovered it, Daniel Elmer Salmon (the other was Theobald Smith). They first found 
Salmonella in hogs that were ill with a disease called hog cholerae [26]. 
 
Salmonella is a gram-negative rod, facultative anaerobic, flagellated bacterium, has a 
growth rate, or division rate, of 40 minutes, prefers to grow at 37°C, but has the 
ability to grow at a wide range of temperatures, from 6 to 46°C. This provides 
Salmonella with many opportunities to grow. Optimum growth occurs at a pH of 6.5-
7.5. It is the pathogenic agent of salmonellosis, a major cause of enteric illness and 
typhoid fever, leading to many hospitalizations and a few rare deaths if no antibiotics 
are administered. Salmonella outbreaks are linked to unhygienic food preparation, 
cooking, reheating and storage practices. The bacterium can be isolated from raw 
meat and poultry products as well as from milk and milk-based products [26,27]. 
 
Salmonella is a ubiquitous human and animal pathogen. This genus contains > 2,500 
recognized serotypes and is divided into two species, Salmonella bongori and 
Salmonella enterica. Salmonella enterica consists of six subspecies (i.e., enterica, 
salamae, arizonae, diarizonae, houtenae, and indica) [28]. Serovars of the bacterium 
Salmonella enterica subsp. enterica are known to be a significant cause of foodborne 
illness in humans. It is well established that different serovars can be associated with 
different animals e.g., S. enteritidis in poultry, which act as a source of foodborne 




Salmonella enterica subsp. enterica serotypes can also be divided into subdivisions 
according to their host adaptation. For example Salmonella serotypes can be divided 
into (i) host-restricted Salmonella serotypes (i.e., serotypes exclusively associated 
with one particular host, e.g., Salmonella Typhi and Paratyphi A); (ii) host-adapted 
Salmonella serotypes (i.e., serotypes prevalent in one particular host species, but able 
to cause disease in other host species, e.g., Salmonella Choleraesuis); and (iii) 
unrestricted Salmonella serotypes (i.e., serotypes capable of causing self-limiting 
gastroenteritis and, less commonly, systemic disease in a wide range of host species, 
e.g., Salmonella Typhimurium). Salmonella Paratyphi A also causes typhoid fever, 
although the symptoms are typically milder than those caused by Salmonella Typhi 
[30].  
 
Non-typhoidal Salmonella serotypes are responsible for gastroenteritis in humans 
and other animals. These serotypes are mainly transmitted by ingestion of food, or 
water contaminated with infected feces [31], but can also be transmitted by direct 
contact [32,33]. Disease caused by non-typhoidal Salmonella is one of the most 
common bacterial foodborne diseases worldwide [34]. Salmonella Typhimurium is 
one of the most common non-typhoidal Salmonella serotypes, is found worldwide, 
and can cause disease, predominantly self-limiting gastroenteritis, in a large number 
of animal species [30]. Because of the abuse of antimicrobial drugs, the antibiotic 
resistance of Salmonella strains from humans is expected to increase. It has been 
reported that there has been an increase in antibiotic resistance of Salmonella isolates 
from humans [35]. 
 
The detection of Salmonella therefore remains a highly important issue in 
microbiological analysis for food safety and standards [36], and to guide clinicians in 
the diagnosis of enteric pathogens [37]. 
 
2.4.2 Shigella spp.  history 
 
Kiyoshi Shiga discovered shigella during an outbreak in Japan in 1897, which 
investigated 36 shigellosis patients and identified the bacilli as the etiology agent in 
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1898 [38]. To acknowledge him for his discovery, the 1930 Edition of Bergey’s 
Manual of Determinative Bacteriology formally renamed the genus as ‘Shigella’ 
[39]. 
 
Shigella is gram-negative rods, non-motile, belonging to the family 
Enterobacteriacae. The genus Shigella includes four species: S. dysenteriae, S. 
flexneri, S. boydii and S. sonnei designated groups A, B, C and D, respectively. All 
species of Shigella cause acute bloody diarrhea by invading and causing patchy 
destruction of the colonic epithelium. This leads to the formation of micro-ulcers and 
inflammatory exudates, and causes inflammatory cells (polymorphonuclear 
leucocytes, PMNs) and blood to appear in the stool. The diarrheal stool contains 106-
108 Shigellas per gram. Environmental conditions like dryness or direct exposure to 
sunlight may lead to the death of the organism due to its sensitivity. The first three 
species include multiple serotypes. S. sonnei and S. boydii usually cause relatively 
mild illness in which diarrhea may be watery or bloody. S. flexneri is the chief cause 
of endemic shigellosis in developing countries [40], while S. sonnei is the most 
commonly isolated species in developed countries, representing over 70% of the total 
isolates in the United States of America [41] and 87% in occupied Palestine [42]. 
 
Shigellosis is an ongoing global public health problem. Due to the fecal-oral 
transmission route of the organisms, the overwhelming burden of shigellosis is found 
in resource-poor settings with inadequate sanitation [43,44]. With an estimated 
number of episodes exceeding 90 million per annum in Asia alone, shigellosis 
represents a significant proportion of the total number of bacterial gastrointestinal 
infections worldwide [45]. Unlike other related bacteria which can cause a particular 
disease syndrome in specific locations (e.g. Salmonella Typhi) [46], it is a disease 
which "bridges the gap" between industrialized and developing countries. A report 
from the National Centre for Infectious Diseases in the United States of America 
found the incidence of shigellosis to be 7.6 cases per 100,000 persons in 1993 [41]. 
 
Shigella species the causative agent of bacillary dysentery (shigellosis) are highly 
adapted human pathogens that are capable of invading and colonizing the intestinal 
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epithelium, which results in severe inflammatory colitis [47]. Shigellosis symptoms  
includes fever, headache, malaise, anorexia and occasionally vomiting, followed by 
excretion of profuse watery diarrhea proceeding bloody and/or mucoid diarrhea [48]. 
 
All the members of the genus Shigella are pathogens restricted to infecting humans 
and exert their effects on the gastrointestinal mucosa via the production of a 
multitude of virulence factors, including enterotoxins and effector proteins [49,50]. 
 
Prompt treatment of shigellosis with appropriate antimicrobial agents not only 
shortens the duration and severity of the illness but also reduces microbial carriage 
and thus spread of infection in the community, but unfortunately emergence of 
antimicrobial resistance has complicated the empirical therapy for treatment of 
shigellosis, due to the prevalence of antimicrobial resistance to some antibiotics used 
to treat Shigella and this resistance differs within Shigella serogroups [51,52]. 
 
The antibiotics recommended by the World Health Organization (WHO) include 
ciprofloxacin, ceftriaxone and pivmecillinam, which are effective in reducing the 
clinical and bacteriological signs and symptoms of dysentery, and thus can be 
expected to decrease diarrhea mortality attributable to dysentery [53]. 
 
Shigella can be isolated from stool samples by culturing it on specific media, and 
simple conventional biochemical's tests are used to identify Shigella species, which 
grouped serologically by slide agglutination with specific antisera. Antibiotic 
susceptibility is usually determined in all samples by disc diffusion method 
according to the Clinical and  Laboratory Standards Institute (CLSI) [54,55].  
 
2.4.3 Campylobacters spp. history 
 
The first description of Campylobacter in the stools of diarrheic children was 
observed by Escherichia in 1886 in Germany and their first isolation was performed 
by McFadyean and Stockman in 1913 [56]. Up until the middle of the 1940’s, these 
bacteria were named Vibrio fetus for those isolated from some animals (ovines, 
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bovines and porcines) abortions, or Vibrio  jejuni and Vibrio coli  for those isolated 
from feces of these animals [57]. The probable implication of these microbes in 
infectious disease of food origin was established in 1946 when Levy described a 
gastroenteritis epidemic in a prison population in Illinois in the United States [58]. 
Until 1963, these microaerophilic vibrios were included in the Vibrio genus. At this 
time, Sebald and Veron proposed the creation of the Campylobacter genus 
(etymologically from the Greek kampulos = curved, bacter = rod) [59]. 
 
Campylobacter is gram-negative, spiral-shaped, has a single polar flagellum, motile, 
non spore forming, sometimes capsulated, microaerophilic bacterium i.e. grow in the 
presence of an atmosphere poor in oxygen, generally between 5 and 10 %. Many 
authors find that Campylobacter is more capnophilic than microaerophilic, i.e. that it 
requires an atmosphere enriched in CO2 to proliferate (generally 10%). Most often, 
but not exclusively, the gaseous mixture appropriate for culture of the microbe is: O2 
= 5%; CO2 = 10%; N2 = 85%. All species of the Campylobacter genus can 
proliferate at 37°C and are true mesophiles, but grow beast from 37°C to 41.5°C 
(Campylobacter coli, jejuni, lari grow beast at 41.5 but usually not Campylobacter 
fetus) and its optimal pH zone is from 6.5 to 7.5, presence of 0.5 % sodium chloride 
(NaCl) in the medium is recommended for culture, whereas concentrations exceeding 
1.5 % tend to inhibit growth [57,60]. 
 
Worldwide, Campylobacter is recognized as the major cause of gastroenteritis and 
diarrheal disease in humans [61-64]. The majority (approximately 90%) of cases of 
Campylobacter gastroenteritis in humans is caused by Campylobacter jejuni, and 
most of the remainder is caused by Campylobacter coli [65]. Poultry, particularly 
chickens, account for the majority of human infections caused by Campylobacter 
[66,67]. Campylobacter jejuni and Campylobacter coli are the most prevalent species 
[62,65,68].  
 
Campylobacteriosis, an acute bacterial enteritis which is a major problem worldwide, 
mostly caused by Campylobacter coli and Campylobacter jejuni. These pathogens 
live in the intestinal tract of most avian species [69].  
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Outbreaks of campylobacteriosis are relatively rare; most infections seem to be 
sporadic [70]. However, the epidemiology of sporadic campylobacteriosis, especially 
the routes of transmission, is to a great extent unclear [71,72]. Internationally it is 
estimated that handling, preparation and consumption of broiler meat may account 
for 20% to 30% of the human cases, however, it has been suggested that chicken as a 
reservoir might account for between 50% and 80% of the cases [73]. 
Campylobacteriosis cases might also be caused by other risk factors than 
consumption and handling of poultry meat like as broiler farms could contaminate 
the environment with further spread to new broiler farms or to humans living in the 
area and local environmental factors, such as climate [74]. 
 
Campylobacter gastroenteritis is a self-limited disease, and antimicrobial therapy is 
not generally required; however, treatment can decrease the duration and severity of 
illness if it is initiated early in the course of infection [75]. Infants, elderly people, 
and immunocompromized individuals are at higher risk of developing more severe 
campylobacteriosis. In these cases, early antibiotic therapy is especially effective 
[76]. 
 
 The primary drugs of choice for treatment of human campylobacteriosis include 
erythromycin and ciprofloxacin. Resistance to ciprofloxacin and erythromycin in 
Campylobacter recovered and occurred more frequently among C. coli than C. jejuni 
[77]. 
 
Rapid and appropriate identification of the etiologic agent of infectious 
gastroenteritis is important, since there are major differences in the treatments 
required for the different agents. C. jejuni and C. coli in human stool samples are 
commonly detected by a bacterial culture test. The test procedure includes culturing 
of the stool on selective agar medium and the subsequent identification of 
Campylobacter-suspected colonies. Several another methods, including a 
commercially available enzyme immunoassay [78], polymerase chain reaction 
(PCR)-based assays [79], and a DNA hybridization-based assay [80], have already 
been reported. Although these assays have excellent sensitivity, they require a 
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comparatively complicated and time-consuming procedure. Their simplicity and 
rapidity appear to be insufficient for routine or emergency use in the microbiology 
laboratory [81]. 
 
2.4.4 Yersinia enterocolitica history 
 
Since the causative agent of plague was first identified as a gram-negative bacterium 
by Alexander Yersin in 1894, our understanding of the epidemiology, genetics and 
evolution of Yersinia has come a long way [82]. Yersinia was classified in the 
Pasteurella genus until 1944 when Vanloghon reclassified them as Yersinia genus in 
family Enterobacteriaceae. Despite similarities with other Enterobacteriaceae 
members, slight differences are exist such as slow growth on solid media, colonies of 
at most 1mm in diameter, and better growth at cooler temperature [83,84]. Metchock 
et al., reported yersiniosis most commonly in cooler months [85]. 
 
Yersinia spp. is gram-negative rods or coccobacilli with bipolar staining that belong 
to the Enterobacteriaceae family [86]. Eleven species are known, but only 3 are 
important human pathogens; Y. enterocolitica is the most common of these, while Y. 
pseudotuberculosis is less frequent, and Y. pesties is rare [87]. 
 
Y. enterocolitica is a zoonotic bacterium causes a variety of gastrointestinal disease 
in humans (Yersiniosis). Clinical symptoms of yersiniosis first appear after an 
incubation period of about 5 days and include diarrhea, fever, vomiting, tenesma and 
abdominal pain. In older children and young adults, abdominal pain in the right 
lower abdomen can occur, which may be mistaken for appendicitis 
(pseudoappendicitis). Typically, symptoms disappear within 1-2 weeks after onset. 
 
Sequelae such as reactive arthritis or erythema nodosum sometimes occur. Y. 
enterocolitica infections are usually sporadic, although outbreaks have been reported. 
Y. enterocolitica species can be isolated from a variety of domestic and wildlife 
animals, e.g., pigs, cattle, sheep, goats, dogs, cats, wild boars, and small rodents [88-
90]. Thought to be primarily transmitted to humans via ingestion of contaminated 
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foods, water and milk or ingestion of uncooked meat products, especially pork 
[88,91]. However, other risk factors, such as pet animal contact, have been reported 
[92]. The majority of cases of enterocolitis are seen in children aged 1-4 years 
[93,94]. Moreover, these infections show a modest predilection for males, with male 
to female ratio of 1.7:1 [95].  
 
Currently, Y. enterocolitica is represented by six biovars (1A, 1B, 2, 3, 4 and 5) and 
more than 30 distinct serovars. The virulence of known pathogenic biovars namely 
1B and 2-5 is attributed to PYV (plasmid for Yersinia virulence) plasmid and 
chromosomally borne virulence factors [96]. 
 
The species encompasses both pathogenic strains including bio/serotypes 4/ O:3 and 
2/O:9 and strains which are classically considered non-pathogenic, namely strains of 
biotype (BT) 1A or non-biotypable strains. However during study in Finland carried 
from January 1st 2006 to December 31st 2006 in 10 clinical microbiology laboratories 
showed that the majority of YE strains isolated from Finnish patients belonged to BT 
1A. The symptoms and sources of patients with Y. enterocolitica biotype (BT) 1A 
(YE BT 1A) were different from the pathogenic YE. In addition, BT 1A patients had 
more unspecific complaints and protracted gastrointestinal disorders, which suggest 
that the original cause of the illness may have been other than YE BT 1A. This is 
supported by the fact, that they did not find any YE BT 1A strains in small children. 
However, it is still possible that in the highly heterogeneous group of YE BT 1A 
there are subgroups that can cause a disease, but this needs further investigations. 
While the significance of the YE BT 1A strains remains unclear, the correct 
registering of infections caused by the truly pathogenic YE strains is essential for 
health protection purposes [97]. 
 
Yersiniosis contributes substantially to foodborne diseases in industrialized countries 
and is therefore notifiable through national surveillance systems in most countries 
within the European Union (EU) [98]. The incidence of yersiniosis is reported to be 
10%-30% in European countries but its a rare disease in Muslim countries (0.06%-
2%) due to the scarcity of pork consumption [83,84].  
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Y. enterocolitica isolates were completely resistant to ampicillin, penicillin, 
cephalotin, and erythromycin [99].  One of the purposes of this work is to investigate 
the presence, isolation, and antimicrobial susceptibility of Y. enterocolitica from 
stool samples of diarrheal patients by microbiological methods using cold-enriched 
media in order to improve the chances of recovering pathogenic Y.  enterocolitica. 
 
2.4.5 Aeromonas hydrophila history 
 
Aeromonas spp. was first isolated from water and diseased animals over 100 years 
ago. Originally, A. hydrophila was identified as one of four Aeromonas species by 
Popo (1984) and he placed it in the family Vibrionaceae [100]. The genus 
Aeromonas currently belonging to the family Aeromonadaceae that includes a group 
of 21-gram negative bacterial species (one of them is A. hydrophila). A. hydrophila is 
a pathogenic bacterium, widely distributed in the environment. Although it is clear 
that members of this genus are primarily aquatic organisms, they can colonize other 
habitats and cause infections in invertebrates and vertebrates [101,102]. Aeromonas 
(principally A. hydrophila) currently has the status of a foodborne pathogen of 
emerging importance [103,104]. 
 
Members of the genus Aeromonas are gram negative rods, facultative anaerobic, 
non-spore-forming, motile by a single polar flagellum, catalase-positive, oxidase-
positive, its neither salt (< 5%) nor acid (min. pH ~ 6.0) tolerant and grows optimally 
at around 28°C. It has the ability to grow at cold temperatures, reportedly as low as 
0.1°C for some strains. It can be metabolize glucose by both the respiratory and 
fermentative pathways and show resistance to the vibriostatic agent O/129. It can be 
divided into two groups: the first includes the psychotrophic Aeromonas, represented 
by Aeromonas salmonicida and the second, by the mesophillic Aeromonas. It 
principal reservoir is the aquatic environment such as fresh water lakes and streams 
and waste water systems [101, 102, 105]. 
Von Graevenitz and Mensch (1968) reported associations of aeromonads with human 
disease in a review of 30 cases of Aeromonas infection or colonization, providing 
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evidence for their recognition as human pathogens and suggesting that some 
aeromonads may be associated with gastrointestinal disease [106]. 
 
In addition, Kirov (2003) notes the potential role of A. hydrophila in human 
gastrointestinal infection. It is able to form lateral flagella on solid surfaces and able 
to produce factors associated with gastroenteritis. These properties are exoproteases, 
exotoxins, cytotoxins, endotoxins, siderophores, invasins, adhesions, S-layers and 
flagella [107,108]. 
 
Gastrointestinal infections of Aeromonas spp. are generally considered waterborne, 
for this reason, A. hydrophila has been placed on the United State of America (USA) 
protection Agency Contaminant Candidate List of emerging pathogens in drinking 
water [109]. 
 
A. hydrophila causes diarrheal infections, most commonly in children's (especially 
those under 5 years) and in immunocompromised patients. The organism is being 
isolated lately with high frequency from patients with traveller's diarrhea [110, 111]. 
 
There has been an increasing incidence of antimicrobial resistance among 
Aeromonas spp. from both environmental and clinical sources [112,113]. A study in 
2006 observed antibiotic resistance in 48% of the Aeromonas isolated from oysters 
[114]. 
 
 So the Food and Agriculture Organization / World Health Organization  
(FAO/WHO) commission recommends that to prevent waterborne disease in 
developing countries, aquatic environments directly impacting human  populations  







2.5 Epidemiology and antimicrobial resistance of gastroenteritis 
pathogens 
   
In a local study in El-naser hospital from 1999 to 2006, the results showed that the 
isolation frequency was 65/3570(1.8%) for Salmonella spp. and 28/3570(0.8%) for 
Shigella spp., Shigella flexneri (16/28) was the most frequently isolated Shigella spp. 
Most of the Shigella isolates were resistant to trimethoprim-sulfamethoxazole (89%), 
ampicillin (79%) and chloramphenicol (46%), whereas most of the Salmonella  
isolates showed resistance to ampicillin (62%), trimethoprim-sulfamethoxazole 
(35%), chloramphenicol (35%) and cephalexin (26%) [116]. 
 
In an Egyptian study on 714 patients with diarrhea, they found that 14% were 
Enterotoxigenic Escherichia coli (ETEC)-associated diarrhea, 1.0% Campylobacter-
associated diarrhea and Shigella-associated diarrhea represented 2%. Children with 
Shigella or Campylobacter-associated diarrhea were reported as watery diarrhea and 
rarely dysentery. ETEC did not have any clinically distinct characteristics [117]. 
 
In a study in Jordan investigated the polymicrobial infections in 220 children with 
diarrhea in a rural population, potential pathogenic agents isolated from 143(65%) 
children were identified by molecular and standard microbiological methods. Co-
infections with two or more agents were detected in 50(35%) of cases. Escherichia 
coli, Shigella spp., Giardia and Entamoeba histolytica were found to be predominant 
[118]. 
 
Another study in Jordan investigated the enteropathogens associated with cases of 
gastroenteritis in a rural population in 180 children. Pathogens and potential 
enteropathogens were identified in 140(77.8%) of the patients, with more than one 
pathogen being recovered from 67(37.2%) of the patients. Potentially pathogenic 
parasites were observed in 90(50%) patients; those that were associated significantly 
with diarrhea were Giardia lamblia, Blastocystis hominis, Cryptosporidium spp., 
Entamoeba histolytica and Cyclospora cayetanensis. Pathogenic bacteria were 
isolated from 72(40%) patients, and, of these, 62.5% were resistant to at least one 
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antibiotic, and 30.6% of these were multidrug resistant. Diarrheagenic Escherichia 
coli strains were found in 14.3% of the samples. The most common enteropathogenic 
bacteria found were Shigella spp., Campylobacter jejuni and Y. enterocolitica [119]. 
Analysis of 1967 Non typhoidal salmonella (NTS) isolated from clinical samples 
between 1990 and 2006 at the AgaKhan University (AKU), a tertiary care hospital in 
Karachi, Pakistan, showed a significant increase in ciprofloxacin resistance from 
23% in 2002 to 50.5% in 2006, with increased mean minimum inhibitory 
concentration (MIC) values from 0.6 to 1.3 µg/mL. Ceftriaxone resistant NTS also 
increased and Extended spectrum beta-lactamase (ESBL) production was seen in 
98.7% isolates. These isolates exhibited high resistance against 
amoxicillin/clavulanic acid (57%), gentamicin (69%), amikacin (44%) and 
piperacillin/tazobactam (30%). No resistance to carbapenem was seen. Ceftriaxone 
resistance was significantly higher in children < 1 year, in invasive isolates and in 
Salmonella Typhimurium [120]. 
A study was conducted to determine the etiology of diarrhea in a hospital setting in 
Kolkata, India. Active surveillance was conducted for 2 years on two random days 
per week by enrolling every fifth diarrhea patient admitted to the Infectious Diseases 
and Beliaghata General Hospital in Kolkata. Most of the patients (76.1%) had acute 
watery diarrhea in association with vomiting (77.7%) and some dehydration (92%). 
Vibrio cholerae O1, Rotavirus and Giardia lamblia were the important causes of 
diarrhea. Among Shigella spp., S. flexneri 2a and 3a serotypes were most 
predominantly isolated. Enteric viruses, Enteropathogenic Escherichia coli (EPEC) 
and Enteroaggregative Escherichia coli (EAEC) were common in children <5 year 
age group. Atypical EPEC was comparatively higher than the typical EPEC, 
multidrug resistance was common among V. cholerae O1 and Shigella spp. including 
tetracycline and ciprofloxacin. Polymicrobial infections were common in all age 
groups and 27.9% of the diarrhea patients had no potential pathogen [121]. 
Other study was carried out to detect the bacterial agents associated with bloody 
diarrhea in children and to determine their antimicrobial susceptibility patterns 
between June 2001 and January 2008. 249 children with bloody diarrhea were 
21 
 
studied, Shigella and Shiga toxin-producing Escherichia coli (STEC) were recovered 
from 48(19.3%) and 3(1.2%) of the total of cases, respectively. In 49 out of 249 
children, in whom other enteropathogens were investigated, recovered 
Campylobacter jejuni from 7 children (14.3%), Salmonella spp. from 2(4.1%) and 
Aeromonas spp. from 1(2%) in addition to Shigella from 7 children (14.3%). Thirty-
four (70%) Shigella isolates showed resistance to ampicillin and 13(27%) to 
trimethoprim-sulfamethoxazole. All Shigella isolates were susceptible to nalidixic 
acid, ciprofloxacin and ceftriaxone. Salmonella and STEC isolates were susceptible 
to all antibiotics assayed. Thus, the use of trimethoprim-sulfamethoxazole or 
ampicillin would not be appropriate for the empirical treatment of Shigella - 
associated diarrhea [122]. 
A study was carried in Sofia, for the period from 1987 to 2008 to detect 
Campylobacter jejuni and coli from diarrheal patients. The study included patients 
from 0 to over 65 years old. A total of 51,607 faecal samples were screened for 
Campylobacter. C. jejuni and C. coli were detected in 1847(3.58%) of the strains, 
with the highest percentage in 1988 (7.5%) and the lowest in 2006 (0.3%). 
Campylobacteriosis occurred most frequently in the wet months of March, April, 
May and June, with 105, 102, 124 and 141 cases, respectively, and was rare in 
January with 25 cases. The most affected groups were children between 0 and 4 
years of age (52%) and between five and 14 years of age (30%). Campylobacter 
infection occurred in 22% of all bacterial gastrointestinal diseases in the city of Sofia 
during the study period. Salmonella was the most frequently identified pathogen with 
32%, followed by Shigella (30%), Campylobacter (22%) and diarrheagenic 
Escherichia coli (16%). The study shows that Campylobacter plays an important role 
as a bacterial cause of enterocolitis in Sofia, Bulgaria [123]. 
Two hundred fifty children presenting with diarrhea at 2 teaching hospitals in Mosul, 
Iraq over a 9-month period were studied for the presence of Yersinia spp. in stools by 
cold-enrichment culture at 4°C for 21 days. Yersinia spp. was isolated from the 
stools of only 4 patients; 3 isolates were identified as Y. enterocolitica and 1 was Y. 
pseudotuberculosis. One Y. enterocolitica isolated from one case by blood culture. 
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The antibiogram test for the isolates was determined. Cross-reaction between Y. 
pseudotuberculosis and Salmonella Typhi or S. Paratyphi B and between Y. 
enterocolitica and Brucella was detected serologically [97]. 
From August 2005 to August 2007, researchers were conducted a prospective cohort 
study among patients ≥ 18 y hospitalized with community-acquired gastroenteritis in 
a university hospital in Berlin, Germany. Stool samples were examined for 26 
gastrointestinal pathogens, supplemented by serologic tests for antibodies to 
Campylobacter spp., Yersinia spp., and Entamoeba histolytica. 104 were included in 
the study. A non-infectious etiology was diagnosed in 8 patients (8%). In 79 (82%) 
of the remaining 96 patients at least one microorganism was identified, 
Campylobacter spp. (35%) was detected most frequently, followed by Norovirus 
(23%), Salmonella spp. (20%), and Rotavirus (15%). In 46% of the patients with 
Campylobacter spp. infection, the diagnosis was made solely by serology. More than 
one pathogen was found in seventeen (22%) patients [37]. 
In one study, which was carried out, to determine the prevalence of five 
enteropathogen diarrheogenic agents in Mexico City from September 2004 through 
December 2006, all diarrheal samples were positive for one or more enteropathogens. 
The most common enteropathogens in diarrheal samples were E. histolytica / dispar 
(70.3%), Salmonella (ohio 28.3%; Typhimurium 16.3%; infantis 8%; anatum 0.6%; 
Newport 0.3%), G. intestinalis (33%), E. coli (ETEC 13.3%; EPEC 9.3%; 
Verocytotoxin-prtducing E. coli (VTEC) 8.6%; Enteroinvasive E. coli (EIEC) 1%) 
and Shigella spp. (flexneri 1.6%, sonnei 1%). Infections by two (24%), three (16%) 
and four (12%) pathogens were observed [124]. 
In the few cases of acute childhood diarrhea that require antimicrobial therapy, the 
correct choice of the drug depends on detailed previous knowledge of local strains. 
In order to establish such parameters in Salvador, researcher reviewed the results of 
all 260 positive stool cultures of children between 0 and 15 years of age during two 
years at a pediatric tertiary care facility in Salvador, Brazil. Bacterial strains had been 
presumptively identified by culturing in selective media and by biochemical, testing 
and their antimicrobial susceptibility patterns were automatically detected. Data 
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about patients' sex and age, monthly distribution of the cases, pathogens isolated and 
their antimicrobial resistance patterns were recorded. Males corresponded to 55.4% 
of their samples, and most of the patients (42.7%) were between one and four years 
of age. Shigella was the commonest pathogen, being found in 141(54.3%) cultures, 
while Salmonella was found in 100 (38.4%) cultures and EPEC in 19(7.3%). 
Salmonella was the main causal agent of diarrhea in children younger than five years 
old, whereas Shigella was the most frequent pathogen isolated from the stools of 
children between five and 15 years old. The peaks of incidence correspond to the 
periods of school vacations. Shigella presented a very high resistance rate to 
trimethoprim-sulfamethoxazole (90.1%) and to ampicillin (22.0%), while Salmonella  
presented very low resistance rates to all drugs tested [125]. 
One study was undertaken to report the current antibiotic resistance in common 
bacterial enteropathogens isolated in a tertiary care hospital in north India. Stool 
samples from 119 (88 male, 31 female) patients yielded Shigella, Salmonella, Vibrio 
cholerae and Aeromonas. Fifty two per cent (62/119) of patients were children and 
70% were below the age of 5 years old. Twenty-seven patients developed hospital-
acquired diarrhea. Among all enteropathogens, Shigella spp. was the commonest 
followed by non-typhoidal Salmonella (27), V. cholerae O1 El tor serotype Ogawa 
(19), Aeromonas spp. (14), Salmonella Typhi and S. Paratyphi A (2 isolates each). 
Resistance to antimicrobial agents was common among all pathogens. Among 
Shigella an overall resistance of 63.6%, 58.1% and 16.3% was observed for nalidixic 
acid, trimethoprim-sulfamethoxazole and furazolidone respectively. Seven isolates of 
Shigella were resistant to ciprofloxacin, while (18.5%) of non-typhoidal salmonella 
were resistant to ciprofloxacin. V. cholerae were generally susceptible to tetracycline 
(only 1 isolate out of 13 resistant) and other drugs except nalidixic acid (89.5% 
resistance) and trimethoprim-sulfamethoxazole (77.8% resistance) [24]. 
A study was carried out to document the presence of pathogenic A. hydrophila in 
diarrheal stool samples in children at Coimbatore, India. Of the 216 samples, 21 
(9.7%) were positive for A. hydrophila. Among them 20 isolates were resistant to 
bacitracin. Most of the isolates showed multiple antibiotic resistances. Among the 21 
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isolates, protease and haemolysin producers were 100% and 95 % respectively. 
About 76% of the isolates produced slime [126]. 
In Brazil, the prevalence of enteropathogens associated with diarrheal disease in 94 
infants < 5 years old was investigated. Cryptosporidium (85.1%) topped the list of 
parasite isolates, followed by Entamoeba histolytica (56.4%) and Giardia intestinalis 
(4.3%). Four samples contained EPEC (4.3%). Salmonella and Shigella, however, 
were not detected, and only one sample contained Rotavirus (1.1%) [127]. 
In Sao Paulo, Brazil, the etiologic profile of acute diarrhea in 154 children aging less 
than 5 years was studied. Intestinal pathogens were detected in 112(72.8%) cases. 
The association of two or more intestinal pathogens occurred in 47(30.5%) cases. 
The pathogens identified were, Rotavirus; 32(20.8%), bacteria; 53(34.4%), both; 25 
(16.2%), and 2(1.4%) with Giardia intestinalis (in one case associated with 
Rotavirus and in another one associated with bacteria).  Altogether, there were 105 
bacterial isolates; 90 were Escherichia coli (EPEC 27, Diffuse adhering E. coli 
(DAEC) 24, ETEC 21 and EAEC 18), 12 were Shigella spp., 2 were Salmonella spp., 
and one was Yersinia spp. Children with mixed infections (viral and bacterial) had 
increased incidence of severe vomiting, dehydration and hospitalization [128]. 
The trend in isolation of Vibrio cholerae, Shigella, and Salmonella in neonates with 
diarrhea in Bangladesh was investigated. The study population included 240 
neonates who were admitted with acute diarrhea and other medical complications to 
the inpatient department of The International Centre for Diarrheal Disease Research 
(ICDDR) hospital, Dhaka, Bangladesh, in 2001. A single enteric pathogen was 
detected in 71(29.5%), and multiple pathogens were detected in 12(5%) of the 
neonates. Enteropathogens identified were as follows: V. cholerae O1 (17.5%), 
Shigella spp. (9.1%), Salmonella spp. (3.3%), Aeromonas spp. (3.7%), and Hafnia 
alvei in (0.8%) of the neonates [129]. 
In a 12-month period, 561 stool cultures from Yemeni children aged 1-60 months 
and presenting with diarrhea, were analyzed to identify the bacterial etiology and 
their antimicrobial resistance to the commonly used antibiotics. A total of 190 
(33.9%) were positive for bacterial culture. Most of the positive cultures (58%) were 
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from children aged 1-12 months. The majority of the positive cultures were EPEC 
(58.4%), Salmonella spp., and Shigella spp. (20% each). Campylobacter were found 
to be an extremely uncommon agent of childhood diarrhea making only 1.6% of the 
positive cultures. The majority of the Salmonella were group C (60.5%) and group B 
(29%). Of the Shigella isolates, 13(34%) were S. flexneri, and seven (18%) S. 
dysentrea. More than two-thirds of the Salmonella isolates were resistant to nalidixic 
acid, chloramphenicol, trimethoprim-sulfamethoxazole, gentamicin, and amoxicillin, 
while 42% were resistant to cefotaxime. Most of the Shigella isolates were 
susceptible to nalidixic acid and cefotaxime, and resistant to the other antibiotics. All 
the tested EPEC isolates were resistant to amoxicillin, 83% were resistant to 
trimethoprim-sulfamethoxazole, 62% to chloramphenicol, and 54% to gentamicin, 
while only 16 and 6 % were resistant to nalidixic acid and cefotaxime, respectively 
[130]. 
Researchers studied microorganisms associated with infant diarrhea in a group of 
256 children admitted to a public pediatric hospital in Montevideo, Uruguay. 
Diagnostic procedures were updated to optimize detection of potential pathogens, 
which were found in 63.8% of cases, and to be able to define their characteristics 
down to molecular or antigenic type. Mixed infection with two or more agents was 
detected in more than one-third of positive cases. Escherichia coli, especially 
(EPEC), were shown to be prevalent. Rotavirus, Cryptosporidium, Campylobacter 
(mainly Campylobacter jejuni), and Shigella flexneri were also often identified. 
ETEC, Salmonella, and Giardia lamblia were sporadically recognized. Unusual 
findings included two EIEC strains, one Shigella dysenteriae, and a non-O:1 Vibrio 
cholerae culture. EPEC bacteria and S. flexneri (but not Salmonella) showed 
unusually frequent antimicrobial resistance, especially towards beta-lactam 
antibiotics, which is the subject of ongoing work [131]. 
A group of researcher in Gaborone, Botswana investigated the Shigella and 
Salmonella strains isolated from 221 children under 5 years, and their antibiotic 
susceptibility patterns. They isolated Shigella and Salmonella from (21%), (3%) 
respectively. S. boydii (13%) was the most prevalent Shigella species followed by S. 
flexneri (6%) and S. sonnei (2%). Salmonella species were S. Typhimurium and S. 
26 
 
Paratyphi. Antibiograms of the predominant isolates showed that most Shigella 
species were resistant to ampicillin but susceptible to chloramphenicol. The 
Salmonella species were susceptible to chloramphenicol, collistin-sulphate, 
gentamicin, trimethoprim-sulfamethoxazole, and ampicillin [132]. 
In a study in Jeddah, Saudi Arabia, investigating the prevalence of viral, bacterial 
and parasitic enteropathogens among young children with acute diarrhea, in 576 
fecal samples collected from children < 5 years old  suffering from acute diarrhea 
and attending hospitals and outpatient clinics. One or more enteropathogens were 
identified in 45.6% of the stool samples. Mixed infections were detected in 12.2% of 
the diarrheal cases. Rotavirus was detected in 34.6% of the samples of the 
hospitalized patients and in 5.9% of the samples of the outpatients. Other etiologic 
agents recognized included Escherichia coli (13%), of which 3.8% were (EPEC) and 
1.9% enterohaemorrhagic E. coli. Other detected pathogens were: Klebsiella 
pneumonia (4%), Giardia intestinalis (3.1%), Salmonella spp. (3%), Shigella flexneri 
(2.6%), Entamoeba histolytica (2.2%), Trichuris trichiura, Hymenolepis nana, and 
Ascaris lumbricoides (0.7% each), and Candida albicans (0.5%) [133]. 
The prevalence of enteropathogens associated with diarrheal disease in 130 infants 
living in the poor urban areas of Porto Velho, Brazil, was investigated. 80% of 
diarrheal cases were observed in the groups under 2 years of age. Rotavirus (19.2%) 
was the most frequent enteropathogen associated with diarrhea, followed by Shigella 
flexneri (6.15%) and S. sonnei (1.5%) and Salmonella spp. (6.9%). ETEC infections 
(3.1%), EPEC (2.3%), EIEC (0.8%) and Y. enterocolitica (0.8%). Mixed infections 
were frequent, associating Rotavirus, EPEC and Salmonella spp. with Entamoeba 
histolytica and Giardia intestinalis [134]. 
The incidence of enteric pathogens was investigated in 265 Jordanian children 
suffering from gastroenteritis using PCR and conventional methods. They detected 
enteropathogens in 66.4% of the examined children. A single enteric pathogen was 
detected in 50.9% of the children, and multiple pathogens were detected in 15.5%. 
The prevalence of enteropathogens identified was as follows: Rotavirus (32.5%), 
EPEC (12.8%), EAEC (10.2%), ETEC (5.7%), Shigella spp. (4.9%), Entamoeba 
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histolytica (4.9%), Salmonella spp. (4.5%), Campylobacter jejuni/coli (1.5%), 
Cryptosporidium spp. (1.5%), EIEC (1.5%), Giardia intestinalis (0.8%) and Y. 
enterocolitica (0.4%). No Vibrio cholerae, STEC, microsporidia, adenovirus or 
small round viruses were detected [135]. 
In the USA, the regional variation in the incidence of laboratory-confirmed bacterial 
foodborne illnesses was studied. 12,125 cases were identified. The incidence per 
100,000 population was highest for Campylobacter (15.7%), followed by Salmonella 
(14.4%), and Shigella (7.9%). Lower incidences were reported for E. coli O157 
(2.1%), Yersinia (0.4%), Listeria (0.3%) and Vibrio (0.2%). The incidence of 
Campylobacter and Salmonella among infants proved particularly high, although 





















MATERIALS AND METHODS 
 
3.1 Materials 
3.1.1 Bacterial culture media 
• Salmonella-Shigella agar (BioMerieux, France). 
• Xylose Lysine Deoxycolate agar (BioMerieux, France). 
• Hektoen Enteric agar media (BioMerieux, France). 
• Selenite broth base (OXOID, England). 
• Campylobacter Blood-Free Selective Agar Base (Modified CCDA-Preston) 
(OXOID, England). 
• CCDA selective supplement (OXOID, England). 
• Yersinia selective agar Base (Difco, USA). 
• Yersinia antimicrobic supplement CN (Difco, USA). 
• Muller Hinton agar (BioMerieux, France). 
• MacConkey agar (BioMerieux, France). 
• Buffered peptone water (Difco, USA). 




• Gram stain (BioMerieux, France). 
• Oxidase test (Hy.laboratories Ltd, Occupied Palestine). 
• Catalase test (BioMerieux, France). 
• Salmonella O antiserum poly A-I & Vi (Difco, USA). 
• Salmonella H antiserum poly a-z ((Difco, USA). 
• Antiserum Shigella dysenteriae polyvalent A1+A2 (Biorad, France). 
• Antiserum Shigella boydii polyvalent C1+C2+C3 (Biorad, France). 
• Antiserum Shigella sonnei polyvalent (Biorad, France). 
• Antiserum Shigella flexneri polyvalent (Biorad, France). 
29 
 
• The API-20E test kit (BioMerieux, France). 
• The API Campy test kit (BioMerieux, France). 
• McFarland standard 0.5. 




The following supplies were purchased from local suppliers in Gaza strip:    
• Glass slides. 
• Petri dishes. 
• Plastic loop. 
• Sterile cotton swab. 
• Sterile saline. 
• Antibiotic discs (Himedia, India). 
• Sterile cup. 
• Syringe 5ml. 
• Needle. 
• CampyGen (microaerophilic environment pack). 
 
 
3.1.4 Apparatus and equipments 
 
• Incubator 37°C (Jouan, USA). 
• Incubator 28°C (Ari J. levy, Occupied Palestine). 
• Incubator 42°C (Seleta, Switzerland). 
• Anaerobic jar (OXOID, England). 
• Microscope (Olympus, USA). 
• Safety cabinet (BK1, France). 
• Refrigerator (Amcor, Occupied Palestine). 
• Autoclave (Tuttnauer, USA). 
• Vortex Mixer (Digisystem, Taiwan). 
• Balance (Mettler, Switzerland). 
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• Computer (LG, China). 
• Digital camera (Nokia, Finland). 
 
              3.2 Study area 
 
  The study was performed in Primary Health Care Clinics (PHCC) at Ministry of 
Health (MOH) in Gaza strip. The study was conducted during the period from Jan 
2010 to February 2010. Patients were recruited in 6 primary health care centres in 




A total of 132 stool samples were collected from patients with acute diarrhea 
(gastroenteritis). Fresh passed stool samples without any preservatives were collected 
in sterile containers. Cases are patients attending the PHCC for diarrhea (defined as 
the passage of 3 or more loose or liquid stools per day). The age categories of 
patients are < 5 and > 5 years old. In addition, data were collected from 132 healthy 
controls visited the PHCC at the same time of samples collection from the patients. 
Healthy controls had the same characteristics of patients such as (age, gender), 
except the fact they don’t suffer from diarrhea within the last three months or at 
birth.  
3.2.2 Sample transport  
 
All stool samples were transported to the laboratory in the sterile container, and 
transported in an icebox immediately after collection. Samples were completely 
labelled by the necessary data (date, time of collection, sample type, patient name).  
 
3.2.3 Questionnaire 
The questionnaire used in this study-included information about age, sex, domestic 
animals contact, sources of drinking water, symptoms, including the presence of 
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diarrhea….etc (see annex1). Data were collected by interviewing patients, controls or 
patient's guardians. 
 
3.2.4 Permissions and ethical consideration 
 
Ethical approval was obtained from the concerned authorities for sample collection, 
including Helsinki committee, Doctors of the World (Médecins du Monde - France) 
which helped to collect data and financially supported this work. The participating 
patient's guardians signed informed consent. 
 
3.2.5 Data analysis 
 
Data was collected, summarized, tabulated and analyzed using Statistical Package for 
Social Sciences (SPSS) software. The results were presented through tables, and pie 
charts, Chi-square test was used when appropriate. 
 
             3.3 Isolation and identification procedures of enteropathogenic bacteria 
3.3.1 Salmonella and Shigella  
Each stool sample was directly cultured onto Xylose Lysine Deoxycolate agar (XLD) 
agar, Salmonella Shigella (SS) agar, Hektoen enteric (HE) agar. Approximately 1 g 
of each sample inoculated into 10 ml of Selenite F broth. The tubes and plates were 
incubated at 37ºC for 18 to 24 hr. Selective Selenite F broth subcultured onto XLD 
agar, SS agar, and HE agar then the  plates incubated at 37°C for 18 to 24 hr. The 
suspected colonies identified by colony morphology and biochemical characteristics. 
Salmonella spp. appears on SS, XLD and HE agar as colorless colonies with black 
centre owing to H2S production. Shigella spp. colonies identified on SS agar as 
colorless while on XLD and HE agar the colonies appeared as transparent red. 
Standard biochemical tests like analytical profile index (API) 20E system and 
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3.3.2 Campylobacter  
Each stool sample was cultured onto (Modified CCDA). The alkaline peptone water 
was used as enrichment media in which samples were incubated at 42ºC for 24 hr 
and then inoculated onto CCDA. The plates were incubated at 42ºC for 48 hr in 
microaerophilic conditions of growth with CampyGen system (5%O2, 10%CO2 and 
85%N2). Campylobacter jejuni colony morphology may appear as small, mucoid, 
greyish, flat colonies with irregular edges and no hemolytic patterns after 24-48 hr. 
They may also appear as round, convex, entire, glistening colonies 1-2 mm in 
diameter. Certain strains of C. jejuni may appear lightly pink or tan in color. The 
suspected colony of Campylobacter was identified by gram stain and biochemical 
tests such as oxidase, catalase tests and API campy system [138,139]. 
3.3.3 Yersinia enterocolitica 
 For isolation of Y. enterocolitica, each stool samples was cultured onto Yersinia 
selective agar and incubated at 28ºC for 48 hr. The cold enrichment method was used 
in which samples incubated at 4ºC for 3 weeks with phosphate buffer saline (PBS) 
then inoculated onto Yersinia selective agar and MacConkey agar which are 
incubated at 28ºC and 37ºC for 48 hr. The suspected colony growth appear as; red 
centre, transparent borderlines and identified by biochemical testes (API20E system) 
[95]  
3.3.4 Aeromonas hydrophila  
Each stool samples was cultured onto XLD agar, SS agar, HE agar and Yersinia 
selective agar. Approximately 1 g of each sample inoculated into 10 ml of Selenite F 
broth. The tubes and plates were incubated at 37ºC for 18 to 24 hr. Yersinia selective 
agar were incubated at 28ºC for 48 hr. Selective Selenite F broth subcultured onto 
XLD agar, SS agar, and HE agar then the  plates incubated at 37°C for 18 to 24 hr. 
The suspected colonies identified by colony morphology and biochemical 
characteristics. Colonies from any place resembling Aeromonas spp. were screened 
for the production of oxidase. Definitive identification was performed by using 
conventional biochemical methods and API20E system [140]. 
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3.4 Antimicrobial susceptibility for the bacterial isolates 
Disk diffusion testing is one of several phenotypic assays, which can be utilized to 
determine the antimicrobial resistance profile (antibiogramme) of an organism. Disk 
diffusion tests estimate in vitro susceptibility. 
Agar plates were inoculated with standardized inoculums of the bacteria and the 
appropriate antimicrobial disks were placed on the inoculated agar plate. The disks 
used for a disk diffusion assay contain a standardized known amount of an 
antimicrobial agent, which diffuses into the agar when in contact with the agar 
surface. The plates were incubated at 37oC. During incubation, the antimicrobial 
agent diffuses into the agar and inhibits growth of the bacteria, producing a “zone of 
inhibition” around the disk [141].  
Campylobacter spp. were grown in CCDA agar, at 42ºC, under a microaerophilic 
condition (85% N2, 10% CO2, 5% O2), for 48hr. After incubation, all strains were 
suspended in PBS pH 7.4 and the density was adjusted to the 0.5 McFarland turbidity 
standards and inoculated on Mueller-Hinton agar plates supplemented with 5% of 
whole blood. Disks of antimicrobials were then placed onto the plates and were 
incubated at 37ºC under a microaerophilic atmosphere, for 48 hr and the inhibition 
zones were measured [142]. 
3.5 Staining and biochemical tests 
3.5.1 Gram stain 
One small drop of saline was placed on a slide. Colonies of suspected bacteria were 
mixed with saline and smeared over the surface of the slide. The smears are allowed 
to dry thoroughly. The smears are fixed by passing the slide; smear up, quickly 
through the Bunsen flame three times. After cooling, the smears were stained. 
Between each staining reagent, the smear is washed under a gently running tap, 
excess of water tipped off before the next reagent is added [143].  
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3.5.2 Oxidase test  
One colony of the test organism is transferred to a filter paper soaked with oxidase 
reagent (tetramethyl-p-phenylenediamine dihydrochloride). Appearance of a blue 
color within 10 seconds indicates a positive result [143]. 
3.5.3 Catalase test 
A colony is placed at a small spot on a slide. One drop of 3%-H2O2 is added on the 
spot with the bacterial material, examined immediately for evolution of gas, which 
indicates catalase activity [143]. 
3.5.4 API 20 E test 
The (API) 20E strips (BioMerieux) was used as biochemical system for identification 
of gram-negative rod bacteria. The API 20E strip consists of 20 micro tubes 
containing dehydrated substrates. These strips were inoculated with bacterial 
suspension, which reconstitutes the media. The strips were incubated for 18 to 24 hr 
at 37ºC during incubation; metabolism produces changes that are either spontaneous 
or revealed by the addition of reagents. The results were recorded and interpreted 
according to reading table and the identification was obtained by referring to the 
API20E catalogue (BioMerieux, France). 
 
3.5.5 API campy test:  
 
The API Campy strip consists of 20 microtubes containing dehydrated substrates. It 
is made up of two parts. The first part of the strip (enzymatic and conventional tests) 
is inoculated with a dense suspension, which rehydrates the substrates. During 
incubation (in aerobic conditions), metabolism produces color changes that are either 
spontaneous or revealed by the addition of reagents. The second part of the strip 
(assimilation or inhibition tests) is inoculated with a minimal medium and incubated 
in microaerophilic conditions. The bacteria grow if they are capable of utilizing the 
corresponding substrate or if they are resistant to the antimicrobial tested. 
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The reactions are read according to the reading table and the identification is 
obtained by consulting the profile list in the package insert (BioMerieux, France). 
3.6 Specific antisera 
 
Confirmation of the results was performed for Salmonella, Shigella isolates by 
specific antisera. 
 
3.6.1 Serotyping of Shigella spp. 
 
Serological identification of Shigella begins with the use of polyvalent antisera, 
which is used to identify the species (i.e. S. dysenteriae, S. boydii, S. flexneri, or S. 
sonnei). If agglutination is observed with polyvalent antisera, the isolates are then 
tested with the individual monospecific serum found in the polyvalent antisera [144]. 
 
3.6.2 Serotyping of Salmonella spp. 
 
Serotyping of Salmonella strains is carried out by identification of surface antigens 
(LPS, O-antigens) and flagella antigens (proteins, H-antigens). Most commonly, 
strains of Salmonella express two phases of H- antigens but aphasic, monophasic and 






















4.1 Description of study samples 
 
4.1.1 Distribution of the samples in terms of residence area of the study 
samples 
 
This investigation is a matched case-control study with prospective data record. 
Cases (132) are patients attending the health care centre with diarrhea, which defined 
as the passage of 3 or more loose or liquid stools per day. Controls (132) are patients 
attending the PHCC for any other cause and who did not experienced diarrhea within 
the last 3 months or since birth. Cases and controls are matched for the date of 
inclusion, age category, gender and the PHCC. Patients were recruited in 6 PHCC in 
Gaza strip located in Gaza area, Northern area, Middle area and Khan Yunis area 
(Table 4.1) from 26/1/ 2010 to 17/2/2010. PHCC were selected from different 
geographical locations to represent the whole Gaza strip. 
 






Jabalia Martyrs Northern area 25 19% 
Al Zaitoun Gaza area 26 20% 
Sabha Gaza area 24 18% 
Der Al Balah Martyrs Middle area 23 17% 
Al Nusairat Martyrs Middle area 9 7% 
Bander Khan Yunis Khan Yunis area 25 19% 
Total 132 100% 
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4.1.2 Sex and age distribution of the study samples 
 
According to the results (Table 4.2) among cases and controls, female constituted 
(56%) while males were (44%) (P = 0.549). (75%) of cases and controls with age 
group less than 5 years, (25%) more than 5 years, (P = 0.556). 
  
Table (4.2):  Distribution of the cases and controls due to sex and age 











44 116 44 58 44 58 
Male 




75 198 75 99 75 99 < 5 
years 
Age 
  25 66 25 33 25 33 > 5  
years 
 
4.1.3 Socioeconomic status of the study samples 
 
Among cases there was (29.5%) refugee, and (33.3%) among controls is refugee (P = 
0.298). It was found that (15.2%) from cases live in houses with < 5 household 
members, while (19.7%) from controls live in houses with < 5 household members 
(P = 0.209). There were significant differences between diarrhea, and houses with 
low rooms number, and number of household workers (P = 0.019, 0.006 






Table (4.3): Distribution of the cases and controls due to socioeconomic status  
Significance P < 0.05 *  
 
4.2 Isolation and identification of enteropathogenic bacteria 
  
4.2.1 Salmonella and Shigella  
 
All samples were tested for Salmonella and Shigella using colony morphology 
(Figure 4.1), biochemical properties (Figure 4.2), and agglutination with specific 
antisera (Figure 4.3). Among 12 enteropathogenic bacteria isolated, there were three 











Figure (4.1): Colony morphology for Salmonella (A: on XLD and HE, B: on SS 
Agar), and Shigella (C: on HE Agar and SS).  
 
P value  2χ   
Control Case  
% N0. % N0. (n=264) 
 
0.298 
33.3 44 29.5 39 yes Refugee 
status 66.7 88 70.5 93 No 
 
0.209 
19.7 26 15.2 20 <5 Number of 
household 








71.2 94 55.3 73 2-3 
22.7 30 31.8 42 > 3 
 
0.006* 
81.1 107 66.7 88 ≥ 1 Number of 
household 
workers 18.9 25 33.3 44 None 

























Isolation of Campylobacter spp. from stool samples after culturing onto (Modified 
CCDA) (Figure 4.4), incubated at 42oC in microerophilic condition (Figure 4.5) and 
identified by API campy test (Figure 4.6). Among 12 enteropathogenic bacteria 
isolated, there were three Campylobacter spp.: two Campylobacter coli, and one 











      
Figure (4.4): Colony morphology for Campylobacter spp. On (Modified CCDA). 
A    B  
 
A    B  
 
A  B 
41 
 




















Figure (4.6): Identification of Campylobacter spp. by API campy test. 
 
4.2.3 Yersinia enterocolitica 
Isolation of Y. enterocolitica from stool samples after culturing onto Yersinia 
selective agar (Figure 4.7) and identified by biochemical testes (API20E system) 
(Figure 4.8). It was found that among 12 enteropathogenic bacteria isolated there 















Figure (4.8): Identification of Y.  enterocolitica by API 20E. 
4.2.4 Aeromonas hydrophila 
Isolation of A. hydrophila from stool samples after culturing onto XLD agar, SS 
agar, HE agar and Yersinia selective agar (Figure 4.9). In addition, these samples 
were identified by biochemical testes (API20E system) (Figure 4.10), among 12 



























Figure (4.10): Identification of A. hydrophila by API 20E. 
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4.2.5 Number and types of isolated enteropathogenic bacteria among the 
study samples 
 
Using standard bacteriological culture methods, twelve enteropathogenic bacteria 
were detected in twelve cases (9.1%) of the 132 stool samples examined. Figure 
(4.11) shows the distribution of enteropathogenic bacteria. Salmonella, 
Campylobacter coli/jejuni, and A. hydrophilia were isolated in equal numbers from 
samples 3/12 (25% each), Shigella 2/12 (16.7%), and Y. enterocolytica 1/12 (8.3%). 
The two Shigella spp. are Shigella boydii. 
 
 
Figure (4.11): Enteropathogenic bacteria isolated from the samples. 
 
4.2.6 Isolated enteropathogenic bacteria distributed by residence 
 
 
Most of enteropathogenic bacteria 5/12 (41.7%) were isolated from Bander Khan 
Yunis, while 2/12 (16.7%) from Jabalia Martyrs, 2/12 (16.7%) from Al Zaitoun, 1/12 
(8.3%) from Sabha, Der Al Balah Martyrs, and Al Nusairat Martyrs, respectively as 





















Salmonella 1 0 0 0 0 2 3 
Shigella 0 1 1 0 0 0 2 
Yersinia 
enterocolytica 0 0 0 0 0 1 1 
Campylobacter 
coli/jejuni 1 1 0 0 1 0 3 
Aeromonas 
hydrophilia 0 0 0 1 0 2 3 
Total Positive  (%)  16.7% 16.7% 8.3% 8.3% 8.3% 41.7% 100 
* Area1: Jabalia Martyrs, area 2: Al Zaitoun, area 3: Sabha, area 4: Der Al Balah 
Martyrs, area 5: Al Nusairat Martyrs, area 6: Bander Khan Yunis. 
 




From table (4.5), it could be observed that enteropathogenic bacteria were isolated 
with a higher frequency from patients belonging to the age group less than 5 years 
(66.7%), in comparison to (33.3%) of enteropathogenic bacteria isolated from 
patients  > 5  years old. There was a decline in prevalence of all pathogens with 
increasing age. An association was found among isolated enteropathogenic bacteria 





Table (4.5): Enteropathogenic bacteria among the different age groups 
Bacteria 





P value    
  
 No. % No.  % 
0.558 
Salmonella 2 1.5 1 0.76 
Shigella 2 1.5 0 0 
Y.  enterocolytica 1 0.76 0 0 
Campylobacter 
Coli/Jejuni  2 1.5 1 0.76 
Aeromonas 
hydrophilia 1 0.76 2 1.5 
Total 8 6.1 4 3.0 
 
4.2.8 Distribution of enteropathogenic bacteria according to gender 
 
As shown in table (4.6), an equal number of enteropathogenic bacteria were isolated 
from both male and female. From male: Salmonella and A. hydrophilia account for 
(1.5%), whereas Shigella and Campylobacter coli/jejuni account for (0.76%). 
Whoever, for female the percentage was (0.76%) for Salmonella, Shigella, A. 
hydrophilia and Y. enterocolytica, and (1.5%) for Campylobacter coli/jejuni, (P = 
0.736). 
 
Table (4.6): Enteropathogenic bacteria among the gender 
 
bacteria 
Gender   
 
 
P value    
 Male(n=58)  Female(n=74)  







Salmonella 2 1.5 1 0.76 
Shigella 1 0.76 1 0.76 
Y.  enterocolytica 0 0 1 0.76 
Campylobacter 
coli/jejuni 
1 0.76 2 1.5 
Aeromonas 
hydrophilia 
2 1.5 1 0.76 
Total 6 4.5 6 4.5 
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4.2.9 Clinical symptoms in relation to presence of isolated bacteria  
   
Table (4.7) presents the symptoms in relation to isolated enteropathogenic bacteria in 
patients with diarrhea, this table showed that there were no association between 
chronic diseases and the presence of enteropathogenic bacteria because no one had 
chronic disease among the positive culture cases. In addition, most cases (58.3%) had 
mucous in stool, another symptoms present among cases in different rates as fever 
(25%), chills (25%), vomiting (50%), bloody diarrhea (16.7%), and loss of weight 
(33.3%).  
  
 Table (4.7): Clinical symptoms in relation to presence of bacterial enteropathogens. 
 
(n=12)   
Number of household 
members reported 
diarrhea  within 10 days 
before patient’s illness 
<1 >1 
No. % No. % 
10 83.3 2 16.7 
Received antibiotics 
within 4 weeks before 
the beginning of the 
diarrhea 
yes no 
No. % No. % 
1 8.3 11 91.7 
Chronic disease 
yes no 
No. % No. % 
0 0 12 100 
Fever 
No Fever Fever 
No. % No. % 
9 75 3 25 
Chills  
yes no 
No. % No. % 
3 25 9 75 
Vomiting  
yes no 
No. % No. % 
6 50 6 50 
Bloody diarrhea 
yes no 
No. % No. % 
2 16.7 10 83.3 
Mucous in stool 
yes No 
No. % No. % 
7 58.3 5 41.7 
Loss of weight 
yes No 
No. % No. % 
4 33.3 8 66.7 
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4.2.10 Correlation of the socioeconomic status of the study samples with 
isolated enteropathogens 
   
From table (4.8), it could be observed that enteropathogenic bacteria were isolated 
with a higher frequency from patients living in a crowded houses, 10/12 (83.3%) of 
enteropathogenic bacteria isolated from patients who live in houses with  > 5 
household members, while (16.7 %) of isolated enteropathogenic bacteria isolated 
from patients who live in houses with < 5 household members, and also a higher 
frequency of enteropathogenic bacteria were isolated  from patients who live in 
houses with low rooms numbers, whereas 10/12 (83.3%) of enteropathogenic 
bacteria were isolated from patients who live in 2-3 rooms in the house, (16.7%) 
from patients who live in  > 3 rooms in the house. A statistical significant association 
was found between diarrhea and houses with low room's numbers. 
Table (4.8): Socioeconomic status of the study samples with isolated enteropathogenic 
bacteria    
 
Table (4.8): Socioeconomic distribution of the study population with diarrhe 
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4.3 Antimicrobial susceptibility profile 
 
4.3.1 Antimicrobial profile of enteropathogenic bacteria isolated from 
patients  
 
The antimicrobial profile for isolated enteropathogenic bacteria to various 
antimicrobial drugs was determined by the disk diffusion method following the 
recommendations of the CLSI. According to table (4.9) the antimicrobial profile of 
twelve isolated enteropathogenic bacteria showed high resistance rates for 
Campylobacter coli/jejuni (52.4%), followed by Aeromonas hydrophilia (49.2%), 
Yersinia enterocolytica (42.9%), Shigella (26.2%) and Salmonella spp. (22.2%). 
 
In addition, the antimicrobial profile of the isolated enteropathogenic bacteria 
showed that antibiotics resistance (91.6%) to rifampin, (83.3%) to clindamycin, 
(75%) to erythromycin, (66.6%) to cephalexin, (66.6%) to tetracycline, (58.3%) to 
amoxicillin, (58.3%) to cephazolin, (58.3%) to trimethoprim/sulfamethoxazole, 
(41.6%) to nalidixic acid, (41.6%) to doxycycline, (33.3%) to azerotenam, (33.3%) 
to pipracillin, (33.3%) to cefuroxime, (16.6%) to cloramphinicol, (16.6%) to 
cefatoxime, (16.6%) to cefatazidim,   (8.3%) to ofloxacin, (8.3%) to ceftriaxone, 
(8.3%) to ciprofloxacin and (38.6%) to all antibiotics. All isolates were sensitive to 






Table (4.9): Antimicrobial susceptibility of isolated enteropathogenic bacteria 
 
Amoxicillin (AM), Pipracillin (PC), Erythromycin (E), Clindamycin (CD), Cephalexin (CP), Cefuroxime (CU), Cefatoxime (CE), Cefatazidim (CAZ), Ceftriaxone (CI), 
Cephazolin (CZ), Amikacin (AK), Gentamicin (GM), Tetracycline (TE), Doxycycline (DO), Cloramphinicol (C), Trimethoprim/sulfamethoxazole (SXT), Nalidixic Acid (NA), 

















AM\ PC E CD CP CU CE CAZ CI CZ AK GM TE DO C SXT NA CIP AT RA OFX 







Salmonella spp. S S R R I S S S S I S S R R S S R S S R S 28.6 
Salmonella spp. S S R R R S S S S S S S S S S S S S S R S 19 
 Shigella 
spp. 





Shigella  spp. S S R R R S S I S R S S I S S S S S S R S 23.8 
Campylobacter 
coli/jejuni  








































4.3.2 Prescription of antibiotics to the diarrheal patients 
 
About (30.3%) of the patients used antibiotics, trimethoprim/sulfamethoxazole was 
the most antibiotic taken (25%), while amoxicillin (3%), cloxacillin (1.5%), 
ampicillin were less prescribed by treating physician (0.8%), and unknown (0.8%). 
The percentage of patients who received antibiotic within 4 weeks before the 
beginning of the diarrhea was (27.3%) (Table 4.10). 
 
Table (4.10): Prescription of antibiotics to the diarrheal patients 
Diarrhea  (n=132)  
no  yes  
Antibiotic within 4 weeks before 
the beginning of the diarrhoea  
. % No. % No. 
72.7 96 27.3 36 
%  No.  %  No.  
Antibiotic therapy for diarrhea 
 69.7  92  30.3  40  
%  No.  
Trimethoprim/sulfamethoxazole 25  33  
3  4  
Amoxicillin 
0.8  1  
Ampicillin 
1.5  2  
Cloxacillin 







4.4 Correlation of socioeconomic factors with diarrhea 
 
In this study, we collected information from cases and controls about socioeconomic 
factors. In this section, we will correlate these socioeconomic factors with diarrhea in 
Gaza strip. 
 
4.4.1 Correlation between diarrhea and domestic animals in the house 
 
As shown in table (4.11), there are statistically significant differences between the 
presence of poultry and pigeon in the houses and diarrhea because there are poultry 
(26.5%) and pigeon (19.7%) in the cases house while there is poultry (11.4%), and 
pigeon (8.3%) in the controls group. 
On the other hand there are (4.5%), (10.6%), (8.3%) of rabbit, sheep, donkey in the 
cases group respectively while there are (9.1%), (5.3%), (9.1%) of rabbit, sheep, 
donkey in the  in the controls group respectively. This correlation is statistically not 
significant. 
 
Table (4.11): Domestic animals in the house and diarrhea 
*Significance P < 0.05 
  
P value  
Control(n=132) Case (n=132)   
(n=264) 
% N0. % N0. 
  
0.001*  
11.4 15 26.5 35 Yes 
Poultry 
88.6 117 73.5 97 No 
  
0.111  
9.1 12 4.5 6 Yes 
Rabbit 
90.9 120 95.5 126 No 
  
0.086 
5.3 7 10.6 14 Yes 
Sheep 
94.7  125 89.4 118 No 
0.006* 8.3 11 19.7 26 Yes 
Pigeon 
91.7 121 80.3 106 No 
 
0.500 
9.1 12 8.3 11 Yes 
Donkey 90.9 120 91.7 121 No 
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4.4.2 Correlation between diarrhea and some furniture in the houses  
  
As shown in table (4.12) there are association between diarrhea and the presence or 
absence of some furniture in the houses, for example there are statistically significant 
differences between diarrhea and presence of washing machine, cooking utensils in 
the houses because there are (80.3%) of cases had washing machine and (83.3%) of 
cases had cooking utensils, while there were (90.9%) of controls had washing 
machine, (91.7%) of controls had cooking utensils, in the other hand there are no 
statistically significant differences between the presence of fridge, latrine in the 
houses and diarrhea. 
 
Table (4.12): Correlation between diarrhea and some furniture in the houses.   




% N0. % N0.  
  
0.065 
87.9 116 80.3 106 Yes 
Fridge 
12.1 16 19.7 26 No 
  
0.011* 
90.9 120 80.3 106 Yes Washing 
machine 9.1 12 19.7 26 No 
 
0.031* 
91.7 121 83.3 110 Yes Cooking 
utensils 8.3 11 16.7 22 No 
 
0.361 
97.7 129 96.2 127 Yes Latrine in 
the house 2.3 3 3.8 5 No 
Significance P < 0.05 * 
 
4.4.3 Correlation between diarrhea and current water access in the houses 
 
There are statistically significant differences between the current water access in the 
houses and diarrhea because the current water access in the houses of the controls is 
better than in the houses of cases as shown in table (4.13): (Public water access at 
home, water from private provider, roof Jerrican, filtered water home: (85.6%), 
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(62.9%), (88.6%), (3.8%) in cases and (94.7%), (66.7%), (92.4%), (6.1%) in controls 
respectively). 
 
























92.4 122 88.6 117 Yes 
Roof 




6.1 8 3.8 5 Yes Filtered 
water at 
home 
93.9 124 96.2 127 No 
Significance P < 0.05 * 
 
4.4.4 Correlation between diarrhea and drinking water in the house 
 
As shown in table (4.14) tap water in Gaza strip may be contaminated because the 
percent of cases drinking tap water are more frequent than those in controls (11.4% 
in cases, 9.8% in controls). In addition, there is statistically significant correlation 










% N0. % N0. 
0.421 




90.2 119 88.6 117 
No 
0.500 




10.6 14 11.4 15 
No 
0.142 




93.2 123 88.6 117 
No 
0.286 




86.4 114 89.4 118 
No 
0.042* 




97.7 129 92.4 122 
No 
0.247 





74.2 98 69.7 92 
No 
Significance P < 0.05 * 
 
4.4.5 Correlation between diarrhea and sewage disposal 
 
 The use of barrels and cesspool in the house increased diarrhea as shown in table 
(4.15). Cases who used barrel, and cesspool are (11.4%), (13.6%), while controls 
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(8.3%), (11.4%) respectively. Whilst using sewers improve situation of diarrhea and 
diminish diarrheal cases (78% using sewers in cases, 80.3% in controls).  
 
Table (4.15): Sewage disposal and diarrhea 
P value 
Control(n=132) Case(n=132)   Swage 
Disposal 
(n=264)  % N0. % N0. 
0.268 
8.3 11 11.4 15 Yes 
Barrel 
91.7 121 88.6 117 No 
0.355 
11.4 15 13.6 18 Yes 
Cesspool 
88.6 117 86.4 114 No 
0.381 
80.3 106 78 103 Yes 
Sewers 
19.7 26 22 29 No 
0.300 
15.9 21 12.9 17 Yes Sewage 
Disposal 




4.5 Clinical signs and symptoms of diarrheal patients 
 
 
As shown in table (4.16), certain signs and symptoms during diarrhea may be 
dominant  such as mucous in stool (65.2%), or present at low percentage such as 
chills (31.1%), bloody diarrhea (14.4%). Another sign and symptoms were present at 
high percentage are vomiting (50%), loss of weight (50%), and fever (40.9%). Only 








Table (4.16): Clinical signs and symptoms of diarrheal patients 
Sign and symptoms Percentage (n=132) 
Number of household 
members reported 
diarrhea within 10 days 
before patient’s illness 
<1 >1 
No. % No. % 
100 75.8 32 24.2 
Chronic disease 
yes no 
No. % No. % 
7 5.3 125 94.7 
Fever  
 No Fever Fever 
No. % No. % 
78 59.1 54 40.9 
Chills  
yes no 
No. % No. % 
41 31.1 91 68.9 
Vomiting  
yes no 
No. % No. % 
66 50 66 50 
Bloody diarrhea 
yes no 
No. % No. % 
19 14.4 113 85.6 
Mucous in stool 
yes No 
No. % No. % 
86 65.2 46 34.8 
Lost of weight 
yes No 
No. % No. % 
66 50 66 50 
 
4.6 Management and follow-up of diarrheal patients 
  
During management and follow-up of diarrheal patients after one week from 
admission time, its clear that most of cases (78.8%) were recovered, diarrhea 
persisted in (19.7%), referred to hospital (0.8%), new attendance at the same PHCC 
(0.8%), death due to diarrhea (0.0%), lost to follow-up (1.5%), and positive culture 
(9.1%) . 
Dehydration is a very serious consequence of diarrhea, so (48.5%) of cases obtained 
rehydration with oral rehydration salts (ORS) or equivalent, and (2.3%) from cases 
needs to be referred to the hospitals (table 4.17).  
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 No unknown 
No. % No. % No. % 




yes No unknown 
No. % No. % No. % 
26 19.7 104 78.8 2 1.5 
 
Referred to hospital 
yes 







1 0.8 129 97.7 2 1.5 
 
New attendance at the 
same PHCC 
yes 







1 0.8 129 97.7 2 1.5 
 
 
Death due to diarrhea 







0 0 130 98.5 2 1.5 
 
Lost case to follow-up 
yes No 
No. % No. % 




No. % No. % 
12 9.1 120 90.9 
Rehydration with ORS   
yes No 
No. % No. % 
64 48.5 68 51.5 
Needs to be referred to 
the hospital 
yes No 
No. % No. % 
3 2.3 129 97.7 
 
ORS: Oral rehydration salts. 









Each year, an estimated 2.5 billion cases of diarrhea occurs among children under 
five years of age, and estimates suggest that overall incidence has remained relatively 
stable over the past two decades [146]. Diarrheal diseases represent the most 
infectious disease in Gaza strip during 2009 (55.6 %) [147]. Infectious diarrhea 
affects mainly children who are at risk of complications, especially when they suffer 
from malnutrition, which is common in Palestinian children [148]. 
 
Poor sanitation and restriction to water access may favour communicable diseases, 
especially infectious diarrhea, which is one the leading causes of morbidity in the 
Gaza strip [149], and is one of the more frequent reasons for PHCC attendance in 
addition to respiratory tract infections [150]. 
  
This study aims to analyze enteropathogenic bacteria, antibiotic resistance for 
isolated enteropathogenic bacteria and associated-risk factors related to diarrhea.  
 
5.1 Children age less than 5 years old are more susceptible to 
infection 
 
Acute diarrhea is one of the most common illnesses in children and a common reason 
for doctor's visits. Often it can occur in several members of a family or a classroom 
at the same time. Diarrhea is a common gastrointestinal disease occurring as acute or 
chronic forms especially in children. It could be associated with growth retardation 
or even death in children [151]. 
 
According to our results, children less than 5 years old are more susceptible to 
infectious diarrhea because 75% of diarrheal patients belong to this age, and 
enteropathogenic bacteria were isolated with a higher frequency (66.7%) from 
patients belonging to this age group. Many studies are in agreement with our results 
that children age less than 5 years old are more susceptible to infectious diarrhea 
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[152]. Worldwide, diarrheal diseases are a leading cause of pediatric morbidity and 
mortality, with 1.5–2.5 million deaths estimated to occur annually among children 
aged < 5 years [6,153,154].  
 
5.2 Diarrhea and enteropathogenic bacteria is more frequent in 
crowded houses with low rooms number  
  
High morbidity and mortality from infectious diarrhea in Gaza strip, and outbreaks of 
bloody diarrhea are closely related to poverty, malnutrition, and lack of access to 
care. Lack of safe drinking water and proper nutrition, grossly inadequate sanitation 
and hygiene, crowding with lack of household ventilation and personal indoor air 
pollution are all-important living conditions that promote diarrheal diseases in Gaza 
strip. In addition, refugees and internally displaced persons are at especially high risk 
[40,155]. The risk of transmission of endemic communicable diseases, such as acute 
respiratory infections and diarrheal diseases is increased in displaced populations due 
to associated crowding, inadequate, unsafe drinking water, and sanitation and poor 
access to health care [156,157]. 
 
According to this study, diarrhea is more frequent in crowded houses, (84.8%) from 
cases living in houses with   > 5 household members, and most of cases (55.3%) live 
in houses with 2-3 rooms in the house. Moreover more enteropathogenic bacteria 
were isolated from crowded houses, (83.3%) of enteropathogenic bacteria isolated 
from cases live in house with < 5 household member, (83.3%) isolated from cases 
live in houses with 2-3 rooms. These results suggest that there were significant 
differences between diarrhea, and houses with low room's number. 
 
5.3 Diarrhea is more frequent in houses rearing poultry, sheeps, and 
pigeons  
 
Varieties of domestic animals are capable of transmitting disease to people including: 
poultry, and pigeons. According to the results of this study, there was statistically 
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significant correlation between the presence of poultry and pigeon in the houses and 
diarrhea. This is probably because those who live in rural areas and have regular 
contact with livestock are at greater risk of Campylobacter infection (and other 
enteropathogens) [158-161]. Animals can actually pass Salmonella on to other 
animals, as well as to people. Cattle, chicken, and shellfish are not the only food 
animals that can cause a person to become infected with Salmonella. Other animals 
that can harbor Salmonella include turkeys, sheep, and swine [26]. In addition, 
Salmonella, Campylobacter coli/jejuni, A. hydrophilia, Y. enterocolytica can be 
isolated and transmitted from a variety of domestic animals [26,27,162,163]. 
  
Meanwhile, there was no statistically significant correlation between diarrhea and 
presence of rabbit, sheep and donkeys in the houses. This may be due to these 
animals are normally present outside the houses while poultry and pigeon are 
normally present inside the houses and close contact is anticipated. 
 
5.4 Improvement in sewage disposal is vital in the reduction of 
diarrheal diseases 
 
During the 1800's, the inefficient sewage system led to the outspread of infectious 
diseases such as cholera, typhoid, yellow fever, malaria and various other mosquito 
diseases [164]. The underdeveloped wastewater storage and treatment facilities and 
unchecked sewage flow in the Gaza strip further contaminates groundwater [165]. 
In accordance with this study findings, access to proper sewage disposal decreased 
diarrheal infections (78%) uses sewers among cases while (80.3%) uses sewers, 
among controls). While using Barrel, and cesspool in the house increased the 
diarrheal infections because cases who used Barrel, and cesspool were (11.4%), 
(13.6%), while controls (8.3%), (11.4%) respectively. These results may indicate that 
the water-related health problems are wide spread in the Gaza strip, and so United 
Nations Relief and Works Agency (UNRWA) reports that among the infectious 
diseases affecting the refugee population in the Gaza strip, those that have the 
highest rates of occurrence are those directly related to inadequate supplies of safe 
water and poor sanitation: watery diarrhea, acute bloody diarrhea and viral hepatitis 
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[166]. This contamination of water may be caused by the Israeli military operations 
of December 2008-January 2009, which reported to have damaged 2445 meters of 
sewage pipes, the sewage network, including sewage treatment plants and pumping 
stations, suffered damage at four sites. The electricity network was also damaged, 
and the resulting power cuts affected water supplies, wastewater pumping, and 
treatment systems [167]. 
 
Our findings are in agreement with other studies conducted in developing countries. 
One of these studies  was conducted to estimate the prevalence and associated factors 
for acute respiratory conditions and diarrhea among children under the age of five 
years in Iraq in 2000, they found  that history of diarrhea and acute respiratory 
infections were negatively associated with lower socio-economic status, adequate 
disposal of children's stool and dirty water, but the results were inconsistent in terms 
of access to potable water and sanitation facilities possibly due to non-functioning of 
water and sewage plants after the war [168]. Another study in Nicaragua showed that 
simple, low cost interventions that improve water and latrine infrastructure might 
reduce the prevalence of diarrheal disease in the isolated regions of Nicaragua and 
Central America. Many other studies suggested that inadequate sewage disposal 
could be cause infectious diarrhea [169-172]. These studies in addition to our study 
showed that improper treatment of sewage in Gaza strip lead to contaminate drinking 
water and contribute to the transmission of diseases especially diarrhea and acute 
gastroenteritis.   
5.5 Correlation between water access, drinking water and diarrhea 
Drinking water is water used for domestic purposes, drinking, cooking and personal 
hygiene. Access to drinking water means that the source is less than 1 kilometre 
away from its place of use and that it is possible to reliably obtain at least 20 litters 
per member of a household per day. Safe drinking water is water with microbial, 
chemical and physical characteristics that meet WHO guidelines or national 
standards on drinking water quality. Access to safe drinking water is the proportion 
of people using improved drinking water sources: household connection, public 
standpipe, borehole, protected dug well, protected spring, rainwater. About 2.6 
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billion people (half the developing world) lack even a simple (improved) latrine and 
1.1 billion people have no access to any type of improved drinking source of water. 
As a direct consequence, 1.6 million people die every year from diarrheal diseases 
attributable to lack of access to safe drinking water and basic sanitation and 90% of 
these are children under 5, mostly in developing countries [173]. 
For decades, the Gaza strip has been plagued by extremely poor water quality. The 
sole source of fresh water for the Gaza strip is the Coastal Aquifer. This water source 
is deteriorating and contaminated. With more water, being abstracted (pumped) from 
the aquifer annually than natural recharge rates, seawater and surrounding saline 
aquifers intrude into this fresh water source causing salination [165].  
According to our study there was statistically significant correlation between the 
current water access in the houses and diarrhea because the current water access in 
the houses of the controls is better than in the house of cases as shown in table (4.13). 
In addition, tap water in Gaza strip may be contaminated because the percent of cases 
drinking tap water is higher than those in the controls (11.4% in cases, 9.8% in 
controls). There is a statistically significant correlation between using domestic wells 
and diarrhea. It worthy to mention that the Israeli military operations of December 
2008 – January 2009 are reported to have damaged 11 public wells and four 
reservoirs as well as 19920 meters of water pipes  . A total of 5200 households lost 
their roof water tanks, and another 2355 household water tanks were damaged. 
Nearly 10% of the population of the Gaza strip (over 100,000 people) had no proper 
water supply in February 2009. Three months later, 32,000 people still had no proper 
water supply [167]. 
This means the possibility of contamination of tap water and wells in Gaza strip, 
which forced the United Nations (UN) recommending an immediate cessation of use 
of domestic wells to preserve both the health of the aquifer and the health of those, 
that depend on water from it. Poor water quality in Gaza leads to serious health 
concerns, with vulnerable groups such as children suffering most [165]. A study in 
Nigeria showed that there is association between domestic water sourcing practice 
and the risk of developing diarrhea. It is therefore recommended that high premium 
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be placed on improving access to water and improved household hygiene as a way of 
helping to curb diarrhea [174]. Endemic dysentery is associated with faecal 
contamination of water sources [175]. In 2003 in Parbatia, Orissa, Eastern India, an 
outbreak of cholerae associated with an unprotected contaminated well [176]. 
Researchers in Kenyan showed that diarrhea risk was higher among shallow well 
users. Chlorinating stored water, latrines, and rainwater use all decreased diarrhea 
risk; combined interventions may have increased health impact [177]. 
5.6 Sign and symptoms of diarrheal patients 
 
Severity of sign and symptoms of diarrheal patients varies from patient to patient 
depending on the cause and other factors [178]. Diarrhea may be accompanied by 
mucous, chills, vomiting, and fever and lost of weight or an urgent need to use the 
bathroom. Most studies revealed that high number of patients had these sign and 
symptoms, one of them showed that 76.1% presented with acute watery diarrhea, 
(20%) with loose stool, (3.3%) with bloody diarrhea and 0.6% cases with mucoid 
diarrhea, vomiting was a predominant clinical feature in 77.7% cases and 35% 
suffered from abdominal pain [121]. In another study, Cleary showed that bacterial 
gastroenteritis (STEC) usually characterised by the presence of bloody diarrhea, 
mucous in the stools and a high fever [179]. Most studies revealed that high number 
of patients with gastroenteritis had high fever during diarrhea. In a study, 196 
children's assessed between March 1994 and June 1996 at the pediatric emergency 
room of the Teaching Hospital, Universidade de Sao Paulo, the results showed the 
presence of bloody stools was reported in 11%. The second most frequent symptom 
was vomiting, reported in 78.6%. Of whom, 28.6% had three or more episodes in the 
previous 24 hours, fever was measured or presumed by guardians in  (59%) [128]. 
 
In the present study mucous diarrhea were predominant (65.2%), followed by 
vomiting and loss of weight (50%), fever (40.9%), chills (31.1%), bloody diarrhea 
(14.4%). This study supports the conclusions from other studies that bacterial 
enteropathogens induce a clinical illness characterized by fever, mucous diarrhea, 
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chills, vomiting, bloody diarrhea, loss of weight, or various combinations of these 
symptoms [128,178,179].  
 
In this study when comparing sign and symptoms with isolated enteropathogenic 
bacteria, mucoid diarrhea also were predominant (58.3%), fever (16.6%), chills 
(25%), vomiting (50%), bloody diarrhea (16.6%), lost of weight (33.3%).  
 




Yersinia Campylobacter  Salmonella Shigella Clinical Feature  
O O O   Vomiting and nausea 
O  O  O O Bloody stool  
Key: common: O = occurs 
 
5.7 Follow-up and convalescence of diarrheal patients 
Bacterial gastroenteritis is usually self-limited in the otherwise healthy child. Clinical 
recovery is frequently achieved within a few days and excretion of the causative 
organisms continues for a relatively short duration, usually not exceeding a few 
weeks. Most bacterial gastroenteritis do not require or benefit from antibiotic 
treatment [180,181], this in agreement to our study which showed most of cases 
(78.8%) recovered after one week of admission time, but (19.7%) have persistence of 
diarrhea, (0.8%) referred to hospital, and (0.8%) admitted to the same PHCC. No one 
of all dirrahael patients included in this study died from this disease. 
  
In most cases of diarrhea, replacing lost fluid to prevent dehydration is the only 
treatment necessary. Medicines that stop diarrhea may be helpful, but they are not 
recommended for people whose diarrhea is caused by a bacterial infection. If the 
patient stops the diarrhea before having purged the bacteria, he will trap the organism 
in the intestines and prolong the problem. Rather, doctors usually prescribe 
antibiotics as a first-line treatment [182]. If episodes of diarrhea lasting for less than 
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14 days are defined as acute, episodes lasting for more than 14 days are defined as 
persistent [183]. Some pathogens, such as Cryptosporidium, Giardia lamblia and 
(EAEC) are thought to be associated with persistent or acute diarrhea in some 
locations [184]. Most cases of acute infectious diarrhea caused by bacterial enteric 
pathogens are self-limiting and recovered within one week [185,186].   
 
5.8 Prevalence of bacterial enteropathogens 
 
According to our study, 12(9.1%) enteropathogenic bacteria were isolated from (132) 
dirrahael patients. Salmonella, Campylobacter coli/jejuni, and A. hydrophilia were 
isolated in equal numbers from samples 3/12(25% each), Shigella 2/12(16.7%), and 
Y. enterocolytica 1/12(8.3%). The two Shigella spp. are Shigella boydii. Low number 
of isolated enteropathogenic bacteria may be due to the presence of other causes of 
diarrhea such as other enteropathogenic bacteria, parasites and viruses.   
  
This finding is nearly congruent with other local study conducted by Abu Elamreen 
et al., (2007) where they reported that (10%) of their samples had enteropathogenic 
bacteria which screened by conventional culture method [13]. Other studies reported 
higher percentage of enteropathogenic bacteria (17%) in Egypt [117], (40%) in 
Jordan [119]. Meanwhile our finding showed that rate of detection of 
enteropathogenic bacteria is higher than in a local study in El-Naser Hospital carried 
out from 1999 to 2006, which showed that the isolation frequency was (2.6%) for 
Salmonella and Shigella, in addition detection rate of Salmonella spp. and Shigella 
spp. in Palestine are very low (about 3 cases of Shigella spp and 2 cases of 
Salmonella spp.  in 2009) [116].  
 
5.9 Distribution of isolated enteropathogenic bacteria by residence 
 
The Gaza coastal line is 42 km long, between 6 and 12 km wide and covers an area 
of 365 km2. An estimated 1.5 millions people currently live in Gaza strip. Gaza strip 




According to our study, the isolation of enteropathogenic bacteria were as follows; 
5/12 (41.7%) were isolated from Khan Yunis area, 2/12 (16.7%) from Northern 
Gaza, 3/12 (25%) from Gaza zone, 2/12 (16.7%) from Mid zone. It is clear that high 
number of enteropathogenic bacteria was isolated from Khan Yunis area; this may be 
caused by contaminated drinking water. In fact Khan Yunis area lack wastewater 
treatment plant (WWTP). This may cause contamination of groundwater and thus 
drinking water because groundwater is the only significant source of water in the 
Gaza strip [187,188]. On Tuesday 15 December 2009, Al Mezan Centre for Human 
Rights published a report on 'Environment Pollution and Sanitation Problems in 
Khan Younis'. The report presents the serious water health and environmental 
problems faced by the quarter million people living in Khan Younis city due to the 
exacerbating sanitation situation. The report calls for urgent actions to deal with 
these problems, which affect a wide array of human rights in Khan Younis, and 
threaten water and health in the entire southern Gaza strip. This has contributed to 
the deterioration of the underground aquifer, which has reached a critical stage 
during 2009. In a more recent development, the report states, two sewage pools were 
dug in Al Mawasi area; an agricultural area along Khan Younis beach, where the 
south Gaza aquifer is located. The lack of sanitation services pushed many people to 
connect their sewage to them. They have become a serious threat to the underground 
water and deprived the residents of the area from potable water [189].  
 
Also according to the results 2/3(66.7%) of A. hydrophila were isolated from Khan 
Yunis area, this is may be due the wide distribution of A. hydrophila in the 
environment in both fresh and salt water, sewage and soil [190-192]. They are 
present in high numbers in sewage before and after treatment, thus they have been 
proposed as an indicator of sewage-contaminated surface water. Aeromonas spp. 
may colonize drinking water distribution systems and produce biofilms that resist 







5.10 Antimicrobial resistance for isolated enteropathogenic bacteria 
 
Antibiotics were not usually prescribed for gastroenteritis. In view of the high 
prevalence of gastroenteritis, this still means that significant amounts of antibiotics 
are being prescribed for what remains a self-limiting illness. 
 
According to the present study, 30.3% of cases used antibiotics for diarrhea before 
culture result were finished. Trimethoprim/sulfamethoxazole was the most prescribed 
antibiotic (25%), in spite of the resistance rate of trimethoprim/sulfamethoxazole was 
high (58.3%). These results indicate that there are many physicians prescribing 
antibiotics without waiting culture result or they do not request stool culture at all. 
The recognition that antibiotic resistance is caused in part by excessive antibiotic 
prescribing has prompted calls for reform [196-199]. Yet the optimal methods for 
addressing antibiotic resistance problem remain obscure. Because such reform is 
likely to require fundamental changes in physicians behaviour [200-203]. A better 
understanding of physician's perceptions of antibiotic resistance is essential. In 
general, physicians are likely to alter their practice patterns only when their 
knowledge, beliefs, attitudes, and skills are aligned with the ends (a reduction in 
antibiotic resistance) and the means to achieve them [2].  
 
The last decade showed an alarming increase in antibiotic resistance in infections, 
with more than 13 million deaths per year from infections. Inappropriate prescription 
of antibiotics prompted resistance and increased infectious disease mortality in 
developed countries. Aging populations, changes in behaviour and a decline in the 
development of new antibiotics exacerbated a deteriorating situation [2]. 
In this study multidrug resistance was common among Campylobacter coli/jejuni 
which is resistant to (52.4%) of antibiotics, followed by Aeromonas hydrophilia 
(49.2%), Y. enterocolytica (42.9%), Shigella (26.2%), and Salmonella (22.2%). 
 
In addition antimicrobial susceptibility testing of isolated enteropathogenic bacteria 
showed high resistance rate for rifampin, clindamycin, erythromycin, cephalexin, 
tetracycline, cephazolin, amoxicillin, and trimethoprim/sulfamethoxazole. In the 
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other hand, some of isolated enteropathogenic bacteria were completely sensitive to 
antibiotics such as gentamicin, and amikacin.  
 
Study in India showed that resistance to antimicrobial agents was common among all 
pathogens. Among Shigella an overall resistance of (63.6%), (58.1%) and (16.3%) 
was observed for nalidixic acid, trimethoprim/sulfamethoxazole and furazolidone 
respectively. Seven isolates of Shigella (12.7%) were resistant to ciprofloxacin, 
(18.5%) of non-typhoidal isolates were resistant to ciprofloxacin [24]. In another 
study in Yemen, more than two-thirds of the Salmonella isolates were resistant to 
nalidixic acid, chloramphenicol, trimethoprim/sulfamethoxazole, gentamicin, and 
amoxicillin, while (42%) were resistant to cefotaxime. Most of the Shigella isolates 
were susceptible to nalidixic acid and cefotaxime, and resistant to the other 
antibiotics. All the tested EPEC isolates were resistant to amoxicillin, (83%) were 
resistant to trimethoprim/sulfamethoxazole, (62%) to chloramphenicol, and (54%) to 
gentamicin, while only (16%) and (6%) were resistant to nalidixic acid and 
cefotaxime, respectively [130]. Another study in Salvador, Bahia, Brazil showed that 
Shigella spp. presented a very high resistance rate to trimethoprim-sulfamethoxazole 
(90.1%) and low resistance to ampicillin (22.0%), while Salmonella presented very 
low resistance rates to all drugs tested. These data are useful for practitioners and 
they reinforce the need for continuous microbiological surveillance [125]. 
 
Prevalence of resistance traits in gram-negative bowel bacteria may be due to misuse 
of antibiotics in the health care system, which explains the occurrence of invasive 
infections with multiresistant bacilli. These facts are being carefully examined, 
leading to epidemiologic and molecular studies that are important in the laboratories, 
regarding resistance mechanisms of gram-negative bacilli [131]. 
 
5.11 Dehydration caused by diarrhea 
 
Worldwide, 12% of deaths among children less than five years of age are due to 
diarrhea [204]. Almost 50% of these deaths are due to dehydration and most involve 
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children less than one year of age [205]. Dehydration may be mild or severe (figure 
5.1) [178]. 
 
Using ORS solutions began in the 1970s as an effective and inexpensive method of 
treating mild to moderate dehydration [206]. Despite the  success of oral rehydration 
therapy (ORT), its proven efficacy [207] and recommendations for use by various 
organizations [206,208], studies show that ORT continues to be underused globally 
[209], and specifically by physicians in high-income countries [210-213]. A recent 
report showed that ORT is being delivered to only (20%) of the world's children who 
could benefit and that widespread use could prevent (15%) of deaths among children 
under five years [210]. In our study the results showed that ORS is being delivered to 
(45.8%) of patients with diarrhea in Gaza strip. This results better than the world's 
static's, may be due to abundant of ORS in all PHCC; Government or UNRWA. 
Postulated reasons for underuse in the world include the fear of inducing iatrogenic 
hypernatremia, time requirements, questionable efficacy in moderate dehydration, 
and parental preference [19]. 
 
 





5.12 Relation of the weather with isolation rate of enteropathogenic 
bacteria  
 
The current study was done during the winter season, while enteropathogenic 
bacteria are more common in warmer and wetter months, for this reason may be low 
number of enteropathogenic bacteria were isolated from the cases. Many studies 
suggest that enteropathogenic bacteria are more common in warmer seasons 
especially in developing or tropical regions [214]. The prevalence of bacteria in 
gastroenteritis is more frequent than Rotavirus in warmer weather. There is a marked 
seasonality with sporadic rates of enteropathogenic (Salmonella, Campylobacter, 
Shigella) in the United States: the highest rates of infection increase during the late 
spring and peak in June, July, or August. The rise in the number of cases during the 
summer may be due to higher levels of poultry contamination during warmer 
weather, and/or to summer food-consumption patterns, including barbecuing and 
eating outdoors, which may result in food that is undercooked or cross-contaminated 
[215,216]. A study in Australia showed that the total effect over the preceding week 
indicated a relative increase from baseline in the probability of gastroenteritis of 



















CONCLUSIONS AND RECOMMENDATIONS 
  
 
6.1 Conclusions  
 
 
The present study focused on the isolation of enteropathogenic bacteria from stool 
samples, estimation of its antibiotic resistance and associated-risk factors related to 
diarrhea in the Gaza strip. From this study the following conclusions were drawn: 
 
1. Children younger than 5 years old are more susceptible to infectious diarrhea.  
 
2. A higher frequency (66.7%) of enteropathogenic bacteria was isolated from 
patients belonging to the age group younger than 5 years.  
 
3. Diarrhea is more frequent in crowded houses with low room's number, 
(84.8%) from cases living in houses with  > 5 household members. 
 
4. High percentages of enteropathogenic bacteria (83.3%) were isolated from 
crowded houses with  > 5 household member. 
 
5. A higher frequency of enteropathogenic bacteria were isolated from patients 
living in houses with low rooms numbers, where 10/12(83.3%) of 
enteropathogenic bacteria isolated from population who live in 2-3 rooms in 
the houses. 
 
6. Diarrhea is more frequent among peoples living in houses rearing poultry, 
and pigeons. Statistically significant correlation between the presence of 





7. Access to proper sewage disposal decreases diarrheal infections, (78%) uses 
sewers in cases, and (80.3%) uses sewers in controls. 
 
8. There are statistically significant differences between the current water access 
in the houses, using domestic wells and diarrhea. 
 
9. Mucous diarrhea was predominant (65.2%), followed by vomiting and loss of 
weight (50%), fever (40.9%), chills (31.1%) and bloody diarrhea (14.4%).  
 
10. Most cases (78.8%) recovered after one week of admission time, but (19.7%) 
have persistent of diarrhea, (0.8%) referred to hospital, and (0.8%) admitted 
to the same PHCC. No one of all dirrahael patients died during the study 
period. 
 
11. Among (132) diarrheal patients, 12 (9.1%) of enteropathogenic bacteria were 
isolated: Salmonella, Campylobacter coli/jejuni, and A. hydrophilia were 
isolated in equal numbers from samples 3/12 (25% each), Shigella 2/12 
(16.7%), and Y. enterocolytica 1/12 (8.3%). The two Shigella spp. are 
Shigella boydii. 
 
12. High number of enteropathogenic bacteria 5/12 (41.7%) were isolated from 
Khan Yunis area, 2/12 (16.7%) from northern Gaza, 3/12 (25%) from Gaza 
zone, and 2/12 (16.7%) from mid zone. 
 
13. Multidrug resistance was common among Campylobacter coli/jejuni which is 
resistant to (52.4%) of antibiotics, followed by A. hydrophilia (49.2%), Y. 
enterocolytica (42.9%), Shigella (26.2%), and Salmonella (22.2%). 
 
14. Oral rehydration salts (ORS) is being delivered to (45.8%) of cases, and 







In light of the results of this study and the above listed conclusions, the following 
actions are recommended to minimize antimicrobial resistance and risks of diarrhea:   
 
1. Improvement of laboratories in Gaza strip to increase their ability to isolate 
all types of enteropathogenic bacteria especially those, which cannot be 
isolated routinely such as Campylobacter spp., A. hydrophilia and Y. 
enterocolytica, which require special techniques. 
 
2. Establish a reference laboratory, which is able to identify the serotype of  
Salmonella, Shigella and other enteropathogenic bacteria to establish the 
epidemiology of these bacteria.  
 
3. Effective strategies to prevent crowding, improve household ventilation, 
minimise perennial indoor air pollution, and to improve hygiene. 
 
4. Prevent domestic animals access to the houses especially those capable of 
transmitting diseases to peoples including poultry and pigeon.     
 
5. Special attention should be paid to improve the water resource situation in the 
regional level.  
 
6. Combat the health problems created by open sewage pools, and cesspool 
through the construction of sewage networks especially in Khan Younis to 
take all the necessary measures to prevent any environmental risks. 
 






8. Conduct studies on the impacts on the public health and raise people's 
awareness about the risks and prevention, especially with regard to the health 
impacts on children who live near sanitation facilities. 
 
9. Reduce the emergence and spread of antimicrobial-resistant organisms 
through reducing the disease burden, spread of infection and education for 
physician. 
 
10. Further studies is needed in order to provide a broader picture of the burden                
of acute gastroenteritis, antimicrobial-resistant for enteropathogens, risk 
factors related to diarrhea in patients in Gaza strip, and study in prescribing 
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PHCC   Name Code  
   
 
 CASE CONTROL 
Diarrhea q yes q no diarrhea within the 3 last 




Telephone No.   
Date of Birth 
Age category 
_____/_____/__________ 
q < 5  q  > 5 
_____/_____/__________ 
q < 5  q  > 5 
Gender q male  q female q male  q female 
Refugee status q no   q yes q no   q yes 
No. of household member Total: /________/      
 No. <5 years old: /__________/ 
Total: /________/      
N.  <5 years old: /__________/ 
No. of rooms in the house /________/ /________/ 
No. of household workers q none  q ≥1   
         
q none  q ≥1   
 









q no   q yes 
q no   q yes 
q no   q yes 
q no   q yes 
q no   q yes 
 
 
q no   q yes 
q no   q yes 
q no   q yes 
q no   q yes 





Latrine in the house 
 
 
q no   q yes 
q no   q yes 
q no   q yes 
q no   q yes 
 
q no   q yes 
q no   q yes 
q no   q yes 




Current water access 
Public water access at home 
Water from private provider 
Roof Jerrican 
Filtered water at home 
 
 
q no   q yes 
q no   q yes 
q no   q yes 
q no   q yes 
 
 
q no   q yes 
q no   q yes 
q no   q yes 









q no   q yes 
q no   q yes 
q no   q yes 
q no   q yes 
q no   q yes 
q no   q yes ‡ /___________/ 
 
q no   q yes 
q no   q yes 
q no   q yes 
q no   q yes 
q no   q yes 
q no   q yes ‡/____________/ 
Did your water access change 
since January 2009? 
 
q no   q yes 
 
 








q no   q yes 
q no   q yes 
q no   q yes 
 
q no   q yes 
q no   q yes 
q no   q yes 
Did your sewage disposal 
change since January 2009? 
q no  
q yes 
 
q no  
q yes 
 
Clinical data (for case only) 
Duration of diarrhea (days)  q < 24h  q other: /___________/ days 
No. of stools the last 24h /___________/ per day 
No. of household members reported diarrhea within 
10 days before patient’s illness 
 
/_________/       
Received antibiotic within 4 weeks before the 
beginning of the diarrhea 
q no 
q yes ‡ name of antibiotic: /______________/ 
Chronic disease q no   q yes ‡/_________________________/ 




Chills during diarrhea q no   q yes 
Vomiting during diarrhea q no   q yes 
Bloody diarrhea q no   q yes 
Mucous diarrhea q no   q yes 
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Management (for case only) 
Stool culture q no   q yes  
Antibiotic therapy for diarrhea q no   q yes 
If yes: 
Name of antibiotic: /__________________/ 
Duration of antibiotic therapy: /__________/ days 
Rehydration with ORS   q no   q yes 
Needs to be referred to the hospital q no   q yes 
If yes ‡ hospital: /________________/ 
Follow-up (1 week after time admission) 
Recovered  q no   q yes 
Persistence of diarrhea q no   q yes 
Referred to hospital q no   q yes 
New attendance at the same PHCC q no   q yes 
Death due to diarrhea q no   q yes 
Lost to follow-up q no   q yes 
Stool culture results 
Positive 
culture 
q no  q Not performed  q yes  
q Salmonella 
q Shigella 
q Yersinia enterocolytica 
q Campylobacter 
q Aeromonas hydrophila  
q Other: /__________________/  
103 
 
ANNEXE  
104 
 
ANNEXE 3 
